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Orofacial clefts are frequent congenital malformations, which can result from reduced 
contribution of cranial neural crest cells (CNCCs) to the developing cranium. Upon delamination 
from embryonic neural folds, CNCCs migrate to pharyngeal arches, which give rise to mid-facial 
structures. Previously, mutations in the cytoskeletal gene SPECC1L were implicated in rare, severe 
atypical facial clefting. Overexpression of a patient isolated SPECC1L mutation showed disrupted 
association with acetylated microtubules. We show a similar disruption upon overexpression of 
SPECC1L variants isolated from patients with less severe syndromic cleft lip and palate. Severe 
Specc1l deficiency in homozygous mouse mutants is embryonic lethal, showing a reduction in 
pan-AKT levels and arrested CNCC delamination from the neural folds. Staining of adherens 
junction (AJ) proteins is increased in mutant neural folds, consistent with impaired CNCC 
delamination, a process requiring AJ dissolution. In vitro, AJ changes induced by SPECC1L-kd 
are rescued by activating PI3K-AKT signaling. We also looked at cell migration properties of 
SPECC1L-deficient cells in vitro. Collective cell migration is a cooperative process fundamental 
to embryonic development. Wound-repair assays using primary mouse embryonic palatal 
mesenchyme (MEPM), derived from CNCCs, with moderate Specc1l deficiency show impaired 
collective migration with reduced correlation lengths. These data indicate SPECC1L as a novel 
modulator of AJs and PI3K-AKT signaling in CNCC delamination and migration of CNCC-
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Chapter One: General introduction 
1.1 The neural crest 
 A key developmental process which distinguishes vertebrates from invertebrates is the 
contribution made by the neural crest to the cranium, heart and gut (Bronner, 2012). The neural 
crest constitutes a multipotent group of cell populations, which are similar in their shared 
multipotency, migratory infiltration of and contribution to a variety of developing embryonic 
tissues, throughout development. While the cranial neural crest cells (CNCCs) contribute to the 
developing cranial skeleton, the vagal neural crest contributes to the heart and the trunk neural 
crest to the gut. CNCCs are specified within and delaminate from the neural folds, subsequently 
migrating into the first pharyngeal arch to contribute to the bones of the maxilla and mandible. 
 
1.1.1 Emergence of the neural crest from the neuroectoderm: Specification 
 The establishment of neural crest identity begins in the neural plate border (NPB), which 
lies at the interface of the developing neural plate and non-neural ectoderm. This process begins 
prior to neural tube closure, during gastrulation, and the NPB eventually becomes a 
morphologically distinct population as neurulation completes (Bronner, 2012). These induction 
and specification processes require initiating extracellular signaling and subsequent activation of 
NC gene networks, along with other layers of transcriptional regulation (Bronner, 2012). 
 Initially, the NPB arises from the ectoderm covering the embryo, upon gastrulation (Figure 
1.1). This emerging structure shows gene expression relevant to establishing border identity, such 









in time fuse at the dorsal midline to form the neural tube (Smith, 1987). Induction of NC in the 
NPB is initiated by signaling factors secreted by the surrounding non-neural ectoderm and non-
neural plate, such as Bone morphogenetic proteins (BMPs), Fibroblast growth factors (FGF) as 
well as Wnts. Although the NPB also contacts the paraxial mesoderm (PM), the extent, if any, of 
pro-induction signaling originating from it is not fully understood. However, there are some 
indications that the PM may contribute, as a Xenopus study showed that removal of the PM resulted 
in reduced expression of Snail2. Upon reintroduction of the PM, ectodermal explant expression 
was restored, resulting in melanocyte production (Bonstein et al., 1998). 
 Generally, CNCC specification is known to require four overlapping signaling inputs. The 
non-neural ectoderm is known to secrete BMPs and Wnt, while the paraxial mesoderm provides 
these signals, along with FGF. Lastly, Notch/Delta secretion by the overlying ectoderm (Cornell 
& Eisen, 2005). These inputs work synergistically to initiate expression of the genes known as 
NPB specifiers, including numerous transcription factors, such as Zic1, Pax3/7, Dlx5, Msx1/2, 
Gbx2 and AP2 (Li et al., 2009). The products of these NPB specifiers in turn initiate expression 
of the CNCC specifier genes associated with lineage emergence. These include specifying 
transcription factors, such as Snail1/2, which promotes EMT (Cheung et al., 2005), Id3 and c-Myb 
(Bronner, 2012). Twist, c-Myc, Sox 9 and Sox10 participate in EMT and other aspects of CNCC 
maintenance (Taylor & LaBonne, 2005, Honoré et al., 2003).  
 
1.1.2 Delamination: A neural crest EMT required for migration 
 Neural crest exit from the neural tube is a rapid process, taking perhaps less than an hour 
(Ahlstrom, 2009). This process requires temporally sensitive activation and inactivation of 
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multiple gene regulatory networks, as well as a temporally sensitive repression or activation of 
specific cadherins, which is primarily seen in the initial repression of E-cadherin expression, a vital 
event in the early loss of epithelial characteristics (Duband, 2015). Indeed, ectopic cadherin 
expression interrupts CNCC delamination (Acloque et al., 2009). 
 Among the transcriptional regulators fine-tuned to generate an environment friendly for 
EMT, Snail, Zeb and Twist show specific temporal expression patterns (Duband, 2015). The 
transcription factor Snail is a regulator of gene expression enabling EMT, including repression of 
E-cadherin expression (Cano et al., 2000). Similarly, Zinc Finger E-Box Binding Homeobox 1 
(Zeb1) and Snail-3 (Twist) also reduces E-cadherin expression, by binding and repressing its 
promoter region (Sanchez-Tillo et al., 2010).  
 The exit of CNCCs from the neural folds is provoked by bone morphogenetic protein 4 
(BMP-4) activation of SMAD signaling, as well as contributory Wnt signaling, upregulating Snail-
1/2 in the premigratory population, priming the cell for loss of epithelial characteristics (Sakai, 
2005). A related transcription factor, c-Myb, activates expression of Snail-2, in the premigratory 
status (Betancur, 2005). Snail-1/2 activity increases throughout the specification phase, reaching 
a plateau in delamination (Duband, 2015). Upon successful delamination, Snail-1/2 activity is 
repressed by ubiquitination and degradation, allowing a migration-specific pattern of expression. 
Critical to CNCC functions is the transcriptional activator AP2 alpha, whose disruption causes 
severe cranial dysmorphology in mouse (Schorle et al., 1996), as well as the transcriptional 





1.1.3 Migration dynamics and associated matrix substrates 
 Migratory CNCC, the population which contributes to the development of the maxilla and 
mandible, express distinct proteins and interact with each other and their microenvironment in 
specific ways distinct from the other subpopulations, such as the vagal and trunk neural crest 
(McKeown 2013). One such example lies in the selectivity of CNC chemotaxis throughout 
migration. While CNC have shown in vitro and in vivo sensitivities to chemoattractants such as 
platelet-derived growth factor (PDGF) and vascular endothelial-derived growth factor (VEGF) 
(McKeown et al., 2013). However, other NC subpopulations show sensitivities to other factors, 
such as fibroblast growth factor (FGF) and stromal cell-derived factor 1 (SDF1) (McKeown et al., 
2013).  This is one example of NC-environment interactions, which drive and regulate migration. 
 Another example can be found in the selective expression of matrix metalloproteinases 
(MMPs), which cleave the extracellular domains of surface proteins as well as some molecules 
which contribute to the extracellular matrix (ECM) (McKeown et al., 2013). Unlike vagal NC, 
which primarily employs MMPs such as MMP2 and ADAM17/19 or trunk NC which express 
MMP8, CNCs employ ADAM10, 12 and 18 (McKeown et al., 2013). Such difference has 
functional relevance, given the discovery of regulatory factors in the environments of CNC 
migration. One example is the discovery of so-called neural crest exclusion zones, which 
potentially exclude CNC migration through the expression of uncleavable MMP substrates (Kulesa 
et al., 2015). Evidence exists for MMP-substrate pairing as a guiding migratory factor, as work 
done with chick embryo shows that ADAM10 cleavage of cell adhesion protein CD44 allows CNC 
migration into the developing cornea (Huh et al., 2007). 
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 Recently others have described mechanisms affecting both cell-matrix and cell-cell 
interactions synergistically, in CNC migration. Blocking the activity of matrix metalloproteinase 
9 (MMP9) interrupted delamination and migration of CNC. These defects were due to blocking 
the ability of MMP9 to cleave N-cadherin during EMT and the basement membrane protein 
laminin, in migration (Monsonego-Ornan et al., 2009). Rodent models of CNC migration have 
shown subpopulation specificity of other cell adhesion proteins, such as cadherins and integrins. 
CNC show specific expression of Cadherins 6,11 and 19, while vagal-enteric NC also express 
multiple protocadherins, which can interact with host kinases such as Fyn, thus regulating distinct 
aspects of cell behavior (Gumbiner, 2005). 
 However, cell-cell specific interactions also guide NC migration. Throughout their 
journey, CNC typically remains in contact with each other, a movement described as ‘chain 
migration’ (Kulesa et al., 2015). CNC maintain cohesion throughout migration through shared gap 
junctions, tight junctions and other cell adhesions (Kulesa et al., 2015). Interestingly, work 
exploring the impact of reducing the population size of migratory CNC showed that individual 
cells compensated for the loss, clustering together to maintain cohesion and increasing their rate 
of intra-migratory proliferation (Kulesa et al., 2015). This result, when considered with other work 
showing that migratory CNC share cytoplasm via gap junctions, paints a larger picture of 
intracellular cooperation throughout this developmental process (Kulesa et al., 2015). 
 Taking a broader view of migration, two patterns emerge. An early, primary migration 
along the ventrolateral pathway provides the CNC contributing to the cartilage, bone, musculature 
and innervation of the frontonasal skeleton. This process is later joined by a dorsolateral migration 
proximal to the ectoderm, which infiltrates the dermis, generating melanocytes (Erickson & Goins, 
1995). The structures which they each contribute to will now be described. 
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1.1.4 Ultimate structural contributions of the neural crest 
 The cranial skeleton of vertebrates is patterned by CNCCs (Gendron-Maguire et al., 1993). 
The cartilage, bone and nervous tissues generated are produced by CNCC proliferation throughout 
and after migration, generating craniofacial mesenchyme, which is multipotent (Calloni et al., 
2007). This distinguishes CNC from trunk neural crest, which do not differentiate into bone or 
cartilage (Santagati 2003). The CNC originate from two separate populations, emerging from the 
hindbrain and midbrain. The posterior mesencephalic CNC population invades the pharyngeal 
arches to contribute to the maxilla, mandible and other structures. The more rostral diencephalic 
populations contribute to the frontonasal aspects of the cranial skeleton (Santagati & Rijli, 2003). 
 Hindbrain tissue identity varies along the anteroposterior axis, with adjacent 
compartments, known as rhombomeres differing in gene expression as well as the migratory 
pathways their distinct CNC populations will adopt, upon delamination (Santagati & Rijli, 2003). 
Thus, the first pharyngeal arch (PA1), the anlagen of the maxilla, mandible, incus, malleus and 
Meckel’s cartilage, are colonized by CNC originating in the most anterior rhombomeres 1-3 (R1-
3). CNC originating from posterior from posterior R3 through anterior R5 colonize the PA2, which 
gives rise to the stapes and hyoid bone, which is also contributed to by the CNC originating from 
posterior R5 and R6. These migratory streams also contribute to PA3. Finally, R7 colonization of 
PA4 generates supporting hyoid and epiglottic cartilage (Piotrowski et al., 1996).  
 The terminal identities of the tissues derived from each rhombomere are determined in part 
by the initial identity of the rhombomere itself (Hunt & Gulisano, 1991). Each rhombomere has 
an intrinsic identity determined by the variable expression of a set of paralogous homeotic 
transcription factors of the Hox family. The developmental destiny of each CNC population is 
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predetermined by the individual and synergistic expression patterns of the four members of the 
mammalian HOX cluster (Hunt & Gulisano, 1991). In this way, the more evolutionarily ancient 
patterns of hindbrain development are projected upon the more ventral and initially primitive 
pharyngeal arch sequence. 
 
1.1.5 Variations in neural crest migratory patterns 
 Upon delamination, distinct anteroposterior neural crest populations begin their migratory 
invasion of the developing embryo. Broadly, these four populations are either cranial, trunk, vagal 
or cardiac. Cranial neural crest cells undergo dorsolateral migration, giving rise to the mesenchyme 
of the craniofacial prominences, bone, connective and neural tissue, as well as melanocytes. The 
trunk neural crest give also give rise to melanocytes, as well as the vertebral cartilage and dorsal 
root ganglia. Vagal neural crest contributes the enteric ganglia of the developing gut (Le Dourain 
& Teillet, 1973). The Cardiac neural crest gives rise to the large cardiac arteries and septum of the 
developing heart (Le Lievre & Dourain, 1975). 
 These distinct populations show different migratory qualities (Scarpa & Mayor, 2016). As 
the neural crest engage in a form of collective behavior known as collective cell migration (CCM), 
which involves the formation of streams of migrating cells, which transiently contact each other. 
These species -specific migration patterns are dynamic, with respect to the anterior-posterior axis, 
and show a reduction in width and size, proceeding from the head to the trunk, where single-cell 
wide streams are seen (Szabó & Mayor, 2016). 
 Collective migration of neural crest sub-populations is often categorized as being either 
chain-like or streaming migration or as migration of a sheet of cells (Schumacher et al., 2017). 
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These morphologies are generated by a combination of factors, including cell-cell cohesion and 
cell density (Schumacher et al., 2017). Chain migration (Figure 1.2) features continuous contact 
between neighbors or along trails generated by previous migration. Sheet migration requires a high 
cellular density, while streaming migration involves less persistent cell-cell contacts and frequent 






1.1.6 Defining the unique properties of the neural crest 
The cells of the neural crest are unique to vertebrate development and serve unique roles within 
it. An additional unique property of the neural crest is their anatomic origin. Upon gastrulation and 
the subsequent emergence of the three primary germ layers, the dorsal, neuroectodermal 
component of embryonic ectoderm gives rise to the neural plate. Upon receiving inductive 
signaling from the proximal epidermis, the region surrounding the neural plate, the neural plate 
border, gives rise to the neural crest. 
A fundamental property of the neural crest is their ability to reacquire multipotency, after 
having already differentiated into the ectodermal lineage. This reacquisition of multipotency is a 
prerequisite for their unique roles in vertebrate development, as the distinct populations within the 
neural crest ultimately differentiate a second time. This secondary differentiation contributes to a 
diversity of cell lineages throughout the developing body, including cartilage and bone of the 
craniofacial skeleton, melanocytes and smooth muscle, as well as neurons and glia though out the 
trunk. 
Prior to this contribution, cells of the neural crest show an additional property, the ability to 
collectively migrate, maintaining cell-cell adhesions throughout their various migratory paths. 
This collective behavior is necessary for their contribution to embryonic development, as well as 
a being a distinct process separate from the directed individual migration of cells seen in other 






1.2 A synopsis of mammalian palatogenesis 
 The developing pharynx is initially flanked by five distinct tissue outgrowths, which will 
grow because of the proliferation of NC-derived mesenchyme (Ashique et al., 2002) and integrate 
with each other at multiple interfaces, which is disturbed in facial clefting (Tessier, 1976). 
Mammalian palatogenesis is similarly a unification of developing tissues, in the paired palatal 
shelves required for normal maxillary development. 
 Development of the mammalian mouth initially involves five facial prominences 
surrounding it, the frontonasal prominence (FNP), which must integrate with bilateral maxillary 
prominences (MxP). Similarly, paired mandibular prominences (MdP) also fuse, caudal to the 
maxilla, establishing the equivalent template for mandibular development (Figure 1.3). The 
interface of the paired MxPs and FNP form the upper lip and philtrum (Jiang et al., 2006). 
Defective integration of these prominences is one origin of cleft lip (Zaghloul & Brugmann, 2011). 
 Subsequent palatogenesis originates from paired outgrowths of the now integrated MxPs 
and FNP. These outgrowths, palatal shelves, must ultimately grow vertically, undergo elevation 
rostral to the developing tongue, enlarge to complete the void between them, achieve apposition 
at the frontal midline of the body (Figure 1.4) and, all within a very specific developmental window 
which shows little variation in timing for a given species, with disruptions of any of these processes 









1.2.1 Proliferation within the palatal shelves yields outgrowth 
The palatal shelves themselves offer a seemingly simple architecture involving only two 
broad cellular lineages, a polarized epithelium shrouding an enlarging mass of proliferating 
mesenchyme derived largely from the cranial neural crest (Ito et al., 2003). Interactions between 
these two cellular lineages are required for palatal shelf outgrowth (Bush & Jiang, 2012). Such 
outgrowth requires regulation of the cell cycle, ensuring optimal levels of mitosis in outgrowth. 
Epithelial secretion of patched (Ptch), the sonic hedgehog (Shh) receptor is a major driver of 
mesenchymal proliferation, along with Fibroblast growth factor (Fgf) signaling (Lan et al., 2009), 
with interactions between these pathways likely (Bush & Jiang, 2012). 
 
1.2.2 Models of palatal shelf elevation 
 Elevation of the palatal shelves is a rapid process, which occurs in mouse at approximately 
E14.0, taking under an hour (Bush & Jiang, 2012). This rapidity is also the cause of palatal shelf 
elevation being the least understood element of palatogenesis, due to the challenges it presents in 
observing or attempting its recapitulation in vitro. Multiple models have been proposed to explain 
such a rapid tissue reorientation, which include hydrostatic interactions with palatal shelf ECM 
(Goudy et al., 2010) and mechanical force resulting from proliferation (Bush & Jiang, 2012), none 
of which have conclusively answered this question. Interestingly, one of the only genetic models 
of delayed palatal shelf elevation is Zfhx1a (Zeb1). Zeb1 mutant mice consistently show elevation 
delay, without other features associated with defective palatogenesis (Kurima et al., 2011). This 
transcription factor plays a prominent role in EMT, suppressing transcription of epithelial 
cadherin, along with other genes (Batlle et al., 2000), suggesting a role for cell adhesion in 
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elevation. Collective cell migration, involving coordinated movements of cell streams, is 
potentially relevant to palatal shelf development. Deficiency of one of the few known proteins 
which coordinates collective migration, the tumor suppressor Merlin, shows cleft palate in mouse 
(Gritli-Linde 2008). 
 
1.2.3 Signaling induced upon apposition and adhesion of the palatal shelves 
 Upon palatal shelf apposition, adhesion of palatal shelves proceeds anterior and posterior 
to the site of first contact (Bush & Jiang, 2012). As this joining first involves contact between two 
seemingly identical, bilateral epithelia, an exploration of epithelial cell-cell interactions is 
important. Medial-edge epithelium (MEE) interactions between palatal shelves have been shown 
to be essentially temporally sensitive (Jin et al., 2008). Thus, qualities intrinsic to each palatal shelf 
epithelia are likely guiding factors in adhesion. 
 Interestingly, mouse mutants of the transcription factor Irf6 have cleft palate, due to 
abnormal adhesion between the palatal shelves and other oral structures, such as the tongue 
(Ingraham et al., 2006). However, Irf6 expression is activated by another transcription factor, p63, 
disruption of which also causes clefting (Thomason et al., 2010). Both factors are expressed in the 
periderm, a thin epithelium overlying the continuous epithelium underneath. The periderm is a 
transient tissue, which is thought to serve a function in preventing the palatal shelves from fusing 
with other oral structures during outgrowth and elevation (Richardson et al., 2014). Ultimately, 
the cells of the periderm undergo apoptosis, in MEE, upon the medial apposition of the palatal 




1.2.4 Palatal shelf fusion and the completion of the palate 
  The fusion of the now apposed palatal shelves first requires removal of the periderm from 
the MEE, allowing adhesion and subsequently the abolition of the underlying MEE (Tudela et al., 
2002). Palatal shelf adhesion involves TGF-β signaling, with disruption yielding failed adhesion 
and persistent MEE (Kaartinen 1995, Proetzel 1995). Failed MEE removal, which is required for 
the integration of the apposed mesenchyme, is a cause of cleft palate (Proetzel 1995). Proper fusion 
at E15.5 begins at the central meeting point and a subsequent wave of ventral and dorsal adhesion 
(Alexander et al., 2011). This is followed by the anterior fusion with the primary palate (Bush & 
Jiang, 2012). 
 
1.3 Neurocristopathies: Pathologies of the neural crest 
 The disruption of any process involved in embryonic development has pathogenic 
potential. The neural crest is no exception, as a spectrum of diverse pathologies of the neural crest, 
collectively termed neurocristopathies, has been described (Bolande, 1974). Neurocristopathies 
are as varied as are the derivatives of the neural crest. Broadly, neurocristopathies affect 
craniofacial development, as seen in Waardenburg syndrome (Waardenburg, 1951), cardiac 
morphogenesis, as seen in Velo-cardio-facial syndrome (Shprintzen et al., 1981), or intestinal 
innervation, specifically Hirschprung’s disease (Amiel & Lyonnet, 2001). Often, the symptoms of 
neurocristopathies can overlap between two syndromes in the same patient, complicating our 




1.3.1 Neurocristopathies feature orofacial clefting: 
A common feature of multiple neurocristopathies is orofacial clefting, as frequently seen 
in common syndromes such as Van der Woude syndrome, Pierre Robin sequence, Velo-cardio 
facial syndrome and Median facial dysplasia (Venkatesh et al., 2009). Clefting can occur as cleft 
lip only (CLO), cleft palate only (CPO) or cleft lip and palate (CLP) (Sun et al., 2015). Patients 
afflicted by Waardenburg syndrome, which primarily involves mild craniofacial abnormalities 
such as broad nasal root and pigmentation defects. The primary pathogenesis of Waardenburg 
syndrome, which can also involve CP (Yoshida et al., 2016), is due to heterozygous mutations in 
Pax3, a transcription factor involved in NC specification. Pax3 activates expression of AP2 alpha, 
a critical transcription factor in CNCC specification (Plouhinec et al., 2014). 
DiGeorge syndrome patient frequently present CP (Narges et al., 2016). The pathogenesis 
of DiGeorge syndrome (also known as 22q11.2 deletion syndrome) is a microdeletion of variable 
length, in the q11.2 locus of chromosome 22. Work has focused upon the transcription factor Tbx1, 
which functions in the differentiation of post-migratory NC. Indeed, an ENU mutagenesis – 
derived mouse model of Tbx1 disruption shows a range of phenotypes like DiGeorge (Barrett et 
al., 1981). Finally, the symptoms of Goldenhar syndrome include CP and infrequently lateral facial 







1.4 SPECC1L: A novel cytoskeletal protein with a role in craniofacial morphogenesis 
1.4.1 The discovery of SPECC1L mutations in patients with atypical clefts 
 The cytoskeletal crosslinking protein encoded by the gene Sperm antigen with calponin 
homology and coiled-coil domains 1 like (SPECC1L) was first identified as disrupted by a 
balanced chromosomal translocation involving chromosomes 1 and 22 of a female neonate born 
with severe, atypical facial clefts. This rare birth defect affects 1 in every 200,000 live births, and 
is the result of failed fusion of craniofacial prominences. The patient in question also had cleft 
palate (CP) as well as micropthalmia and talipes calcaneovarus deformity. 
An additional SPECC1L mutation, a de novo heterozygous missense mutation, 
p.Gln415Pro (Q415P), was identified in a male neonate with bilateral atypical facial clefts (Saadi 
et al., 2011). In situ hybridization of mouse Specc1l showed prominent expression in the maxillary 
prominence and lateral nasal processes which fail to fuse in atypical clefts, as well as the eyes and 
limbs, at embryonic day E9.5-E10.5.  
 
1.4.2 Aberrant adhesion and migration upon SPECC1L Drosophila ortholog CG13366-kd  
Ubiquitous reduction of CG13366, the Drosophila ortholog of SPECC1L, by RNA 
interference yielded multiple phenotypes suggestive of impaired cellular adhesion and migration, 
which the author named the ‘Split discs’ phenotype, due to the failure of dorsal and ventral 
imaginal discs to properly migrate and adhere to each other. This process is dependent on a class 
of cell adhesion molecules, integrins. Integrins are important to the processes of migration and 
adhesion. Many of the CG13366 knockdown phenotypes suggest defective migration and adhesion 
in development. Specifically, a wing imaginal disc-specific CG13366 reduction showed wing 
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defects involving altered adhesion of the opposing aspects of the developing wing, such as seen in 
integrin mutants inflated and multiple edematous wings (Saadi et al., 2011). 
 
1.4.3 Specc1lb is implicated in a zebrafish model of oblique facial clefting 
Recently, others have employed the zebrafish model to explore how SPECC1L disruption 
results in the rarer and more severe oblique facial clefting described by Saadi et al., (2011), which 
provided the first and currently one of the only genes implicated in this rare genetic anomaly. 
SPECC1L has two zebrafish homologs, specc1la and specc1lb. Specc1lb is expressed in the 
epithelia surrounding craniofacial chondrocyte populations; specc1la disruption did not yield a 
craniofacial phenotype. This led to the question of how Specc1lb disruption could illustrate its role 
in the fusion of craniofacial prominences. 
 The zebrafish ethmoid plate is analogous to the developing palate, which involves the 
fusion of its median and lateral elements, as the frontonasal and maxillary prominences must 
converge in palatogenesis. The authors found that morpholino knockdown of specc1lb resulted in 
failure of the median and lateral aspects of the ethmoid plate to fuse, resulting in bilateral clefts. 
Additionally, the mandible is absent, showing that zebrafish specc1lb is required for upper and 
lower jaw formation, while reinforcing the role demonstrated for SPECC1L in human oblique 
facial clefting (Saadi et al., 2011). Thus, zebrafish specc1lb offers currently the only genetic model 
of oblique facial clefting. 
 Zebrafish palatogenesis requires a proliferative wave in the pharyngeal structures, to allow 
convergence and extension in creating mature craniofacial cartilage. Specc1lb morphants show a 
reduction in the extent of such proliferation, with no increase in apoptosis. As the epithelia 
surrounding chondrocytes play extracellular signaling roles in chondrocyte development, the 
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authors speculate that specc1lb may play a role in that signaling. Thus, upon specc1lb knockdown, 
reduced chondrocyte proliferation is causative in failed extension and subsequent convergence of 
the ethmoid plate anlage. 
 Ultimately, the authors posit that specc1lb is facilitating different developmental processes 
in the mandible and maxilla. The absence of a mandible suggests that specc1lb enables 
convergence of the mandibular prominences, and promotes integration of the aspects of the 
ethmoid plate in the maxilla. Interestingly, zebrafish transcription factor irf6 is required for this 
integration. This transcription factor is also implicated in human clefting (Khandelwal et al., 2017). 
Still, unresolved questions remain. One example can be found in the absent mandible 
phenotype, which is not a feature of human oblique facial clefting, suggesting that specc1lb serves 
prominence-specific functions which may be shared with human maxillary, but not mandibular 
development. Also, a putative role for specc1la has not been explored. Although specc1la 
knockdown did not produce the relevant phenotype, there has been no exploration of whether the 
introduction of specc1la mRNA can rescue specc1lb defects. Ultimately the nature of this gene 
duplication may make a zebrafish model of human SPECC1L deficiency challenging to interpret. 
 
1.4.4 Mammalian in vitro models of SPECC1L deficiency 
 Immunostaining showed that SPECC1L associates with the actin and microtubule 
cytoskeletons and is a cytoskeletal protein. Ectopic Specc1l-GFP localizes to a subset of 
microtubules containing the acetylated form of α-tubulin. This association is abolished by removal 
of the carboxyl-terminal Calponin homology domain (CHD), suggesting that endogenous 
SPECC1L associates with the microtubule cytoskeleton via its interactions with actin, which is 
bound by the CHD of other proteins (Korenbaum et al., 2002). Indeed, overexpression or reduction 
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of SPECC1L results in actin reorganization defects. Overexpression of ObFC patient-mutation 
Q415P fails to associate normally with microtubules. Endogenous SPECC1L also colocalizes with 
filamentous actin and acetylated α-tubulin of the mitotic spindles, suggesting a role for SPECC1L 
in mitosis which would be further confirmed by a publication of the same year (Mattison et al., 
2011). 
 In vitro models of SPECC1L deficiency in mammalian cell lines revealed altered adhesion 
(Saadi et al., 2011). SPECC1L-kd in human embryonic kidney 293 (HEK-293) cells show 
defective adhesion to the growth substrate, but only upon reaching confluence, when they 
collectively detach. Interestingly, the introduction of Matrigel substrate does not restore density-
based alterations in adhesion. Also, SPECC1L-kd HEK-293 cells show reduced filopodia and 
filamentous actin microspikes, which have been described as indicators of impaired adhesion and 
motility (Webb et al., 2003). 
 Actin cytoskeleton reorganization is required for adequate cell adhesion (Calderwood et 
al., 2000) and migration (Ridley et al., 2003). In wound assays using human osteosarcoma cell line 
U2OS, SPECC1L-kd cells fail to migrate into the wound fully, when compared to WT U2OS cell 
cultures given the same amount of time. SPECC1L-kd U2OS osteosarcoma cells show actin 
cytoskeletal defects, in the form of an increase in non-cortical, perinuclear actin stress fibers. 
Promigratory Wnt ligand Wnt5a induces actin cytoskeletal reorganization to facilitate migration 
(Witze et al., 2008). Upon Wnt5a exposure, SPECC1L-kd U2OS fail to reorganize actin at the 
leading edge, perpendicular to the direction of impending migration, as seen in WT U2OS cells. 
 In summary, disruption of SPECC1L causes severe, atypical clefting. SPECC1L deficiency 
disrupts cell adhesion and migration in vitro, offering potential mechanisms underlying defective 
proliferation within or fusion of craniofacial prominences in the pathogenesis of atypical clefts. 
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The role played by SPECC1L in its association with microtubules is disrupted by SPECC1L 
mutation. Facilitation of adhesion and migration in the cells which contribute to craniofacial 
formation would explain the SPECC1L disruption induced pathogenesis of ObFC. Thus, 
SPECC1L plays a critical role in actin-cytoskeleton reorganization that is required for proper facial 
morphogenesis. 
 
1.4.5 A distinct role for SPECC1L in cytokinesis 
 Complementing the foundational work showing that SPECC1L is a cause of orofacial 
clefting, others described an additional, fundamental role for this protein in cytokinesis. This role 
was specific to cell cortex stability and the positioning of the mitotic spindles during anaphase 
(Mattison et al., 2011). These findings have intriguing overlaps with previous research regarding 
SPECC1L, and are also supported by our recent findings, regarding its protein interactors. 
 Initially, the authors sought to identify and describe the functions of novel substrates of a 
protein kinase essential for spindle body formation, mono-polar spindle 1 (MPS1). MPS1 localizes 
to and is involved in centrosome duplication prior to the onset of mitosis. In doing so, they 
identified MPS1-interacting protein 1 (MIP1, SPECC1L) as an MPS1 substrate with dynamic 
localization throughout cell cycle progression.  
 This dynamic localization begins with a prominent association with the actin cytoskeleton 
during interphase, as already described (Saadi et al., 2011). Upon the onset of mitotis early 
metaphase cells initially show SPECC1L association with gamma tubulin found within the 
microtubule spindle network. Throughout anaphase, SPECC1L is associated throughout the 
development of the ingression furrow and the midbody. The authors note that this mitotic 
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expression pattern is reminiscent of the actin-binding protein Anillin, which is required for 
ingression furrow development.  
 Induced depletion of SPECC1L also yielded intriguing insights. Specc1l siRNA 
knockdown in U2OS cells induced a 24 percent increase in bi- and tetra-nucleate cells, after 48 
hours, demonstrating defective anaphase separation of chromosomes. Live cell imaging revealed 
that treated cells exhibited a violent spindle rocking phenotype which often left daughter 
chromosomes intact within one parent cell only. These results suggest that SPECC1L functions in 
stabilizing or positioning mitotic spindles. 
  
1.5 PI3K-AKT signaling 
1.5.1 Introduction 
 One key signaling pathway influencing many of the cellular phenotypes observed 
throughout the course of this study is the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase (PI3K) 
cascade. PI3K is a lipid kinase which generates the specific inositol lipid species required for the 
activation of downstream kinases, such as the serine-threonine kinase v-akt murine thymoma viral 
oncogene homolog 1 (AKT/Protein kinase B), a protein of specific relevance to this study. 
 
1.5.2 Extracellular origins of PI3K activation 
 Inositol lipid signaling via PI3K originates as a response, at the plasma membrane, to a 
variety of extracellular stimuli. Of importance to embryonic development are extracellular growth 
factors, such as Fibroblast growth factors (FGFs), epidermal growth factors (EGFs), Platelet-
derived growth factors (PDGFs) and insulin, via a class of membrane bound receptors 
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characterized as receptor tyrosine kinases (RTKs) (Figure 1.4). Upon ligand bound dimerization, 
RTKs convey growth and survival promoting signaling, in this case, via Ras GTPase, to activate 
PI3Ks. Another such stimulus, via the focal adhesion kinase (FAK) pathway, is triggered by the 
dimerization of membrane bound integrins α and β, in response to cellular encounters with 
components of the extracellular matrix (ECM). A variety of small, signaling molecules, cytokines, 
stimulate PI3K signaling via cytokine activation of Janus kinase (JAK), in the JAK-STAT 
signaling pathway. PI3K can also be activated as a pathogenic response to pathogen-associated 
molecular patterns, via Toll-like receptors (TLR2/4), via Ras-related C3 botulinum toxin substrate 
1 (RAC1) signaling to PI3Ks. These are the known ligands and corresponding pathways of the 
sub-category known as Class IA PI3Ks, the features of which will be described subsequently.  
 
1.5.3 Phosphoinositide chemistry related to PI3K phosphorylation 
Embedded within the plasma membrane are a variety of modified phospholipids capable 
of multiple cellular roles, ranging from membrane deformation in endocytosis to acting as second 
messengers in key signaling cascades, including PI3K-AKT signaling. The inositol ring of 
Phosphatidyl inositol (PI) can be modified via kinase phosphorylation at multiple carbons, yielding 
numerous species. However, it should be noted that other phospho-PI species exist and are 
generated by enzymes not shown. These pathways will also generate substrates for this and other 
phospho-PI pathways (Figure 1.5). 
As an example of this ATP hydrolysis driven phosphorylation, PI phosphorylation by 
Phosphatidyl Inositol kinase 4 (PI4K) at 4′-position yields the monophosphate species PI(4)P. 
Subsequent phosphorylation of the 5′-position by Phosphatidyl Inositol phosphate kinase 1 





extracellular cues, PI3Ks modify this phospholipid messengers, by phosphorylation of the 3′-
position of the inositol ring of Phosphoinositol bisphosphate (PtdIns-3,4,5-P2 or PIP2) yielding 
Phosphoinositol triphosphate (PtdIns-4,5-P3 or PIP3). Both species of phospholipid have specific 
and distinct signaling effects, important to directional migration and cell polarity, generally. Each 
step in this pathway can be reversed by a competing phosphatase, such as SAC1 Suppressor of 
Actin Mutations 1-Like (SACM1L), SH2 domain containing inositol 5-phosphatases (SHIPs) or 
Phosphatase and Tensin Homolog found on Chromosome ten (PTEN). PTEN is the antagonist of 
PI3Ks, generating PIP2 from PIP3 via the cleavage phosphate from the 3′-position of the inositol 
ring (Figure 1.5). Importantly, with respect to this study, increased PtdIns-3,4,5-P3 induces the 
activity of 3-Phosphoinositide dependent protein kinase-1 (PDK-1), ultimately resulting in 
increased levels of activated AKT at the plasma membrane. 
 
1.5.4 The quaternary structures of PI3K 
 The quaternary structures of PI3K are highly modular, allowing for multiple configurations 
of protein subunits, depending upon the needs of the cell. In restricting our consideration to include 
only Class I PI3Ks, a theme emerges, which is the joining of a catalytic and a regulatory subunit. 
 The class I PI3Ks, whose in vivo substrate is specifically PIP2, is a dimer of a phospholipid 
producing p110 catalytic subunit, and a p85 regulatory subunit. The catalytic subunit can be one 
of four structural variants, p110α, p110β, p110γ and p110δ. All of these, except the γ subunit 
possess a p85 binding domain, facilitating dimerization. The p110γ lacks this domain and forms a 
heterodimer with the p101 or p87 regulatory variants. 
 All p110 subunits are comprised of four other common domains, apart from the amino-
terminal p85-binding domain. First is the Ras-binding domain (RBD). The RBD is imagined 
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playing a primordial function in PI3K activation. Evidence of this is found in the slime mold 
Dictyostelium discoideum, which lacks p85 regulatory subunits entirely, and is primarily activated 
by GPCR-triggered Ras. The remaining three domains constitute the PI3K core responsible for 
lipid phosphorylation. The C2 domain is a lipid-binding domain frequently found in proteins 
associated with the plasma membrane. A proximal helical domain is known to frequently facilitate 
protein-protein interactions. Finally, a carboxyl-terminal catalytic domain is the site of lipid 
phosphorylation. These three domains are collectively known as the PI3K core, as they tether lipid 
kinase activity with the plasma membrane. 
 Complementing this is the domain architecture of the p85 regulatory subunit. This protein 
contains multiple Src-homology domains. An amino-terminal Src-homology 3 (SH3) domain is 
thought to possess a GTPase-activating function, suggesting that PI3Ks can functionally 
communicate with small GTPases, such as Rho, Rac and Cdc42. Adjacent to this is a single 
Breakpoint cluster region-homology domain (BH domain). BH domains typically play a role in 
GTPase functions, although it is yet to be demonstrated that this domain is active in PI3Ks. Finally, 
three carboxyl-terminal domains constitute the p85 core, which is a p110-binding domain, flanked 
on each side by a Src-homology 2 (SH2) domain. SH2 domains are typically found in adapter 
proteins, which interact with RTKs, such as the category of receptors which initiate PI3K signaling 
(Figure 1.5). 
 
1.5.5 Phospholipid activation of PDK1 and subsequent activation of AKT 
 In the larger mechanism of phosphoinositide signaling, a less well-understood activity is 
the intermediate activation of AKT by PDK1, a phosphoinositide-dependent protein kinase. The 
regulation of AKT-activating phosphorylation is crucial to the proper coordination of multiple 
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cellular processes, as evidenced by the strong correlation between activating AKT mutations and 
multiple cancers. 
 Upon PI3K activation and subsequent phospholipid function, synthesized PIP3 
accumulates within the cytosolic face of the lipid bilayer. Unstimulated cells have large reserves 
of the monophosphate PtdIns3P. However, upon RTK stimulation, PIP2 and PIP3 levels rise, 
attracting multiple proteins to the membrane, specifically those containing a globular Pleckstrin 
homology domain (PH domain). Both PDK1 and AKT are mostly cytosolic in distribution, in the 
non-active state existing prior to stimulation. It is the PH domain of PDK1 and AKT that induces 
their interaction at the membrane, upon stimulation, as the PH domain has a far higher affinity for 
PIP3 and PIP2, over other PIs (Figure 1.5). 
  AKT is activated at the plasma membrane, via two activating, post-translational 
modifications (PTMs). PDK1 phosphorylation of AKT, at Thr308, which resides in the activation 
loop, or so called T-loop of the kinase domain, is found in combination with another activating 
phosphorylation. This T-loop is a highly-conserved region of multiple kinases, suggesting 
regulatory phosphorylation of it is also a conserved process. The second activating 
phosphorylation is Ser473, in the C-terminal regulatory domain. Interestingly, PDK1 can 
phosphorylate Thr308 directly, but only Ser473 when associated with another kinase, Protein kinase 
N2 (PRK2). There are indications that other kinases, such as the master target of Rapamycin 
complex 2 (mTORC2), can also phosphorylate this residue. Mutation of either site to Alanine does 
not abolish phosphorylation of the other, indicating that these are separate, but not necessarily 
sequential events. Ultimately, activated AKT disassociates from the plasma membrane, to 




1.5.6 Regulation of multiple cellular systems via AKT phosphoregulation 
 Thus far, there are over 200 verified substrates of AKT phosphoregulation, which 
participate in multiple cellular systems, as will be subsequently described. Although these 
substrates are quite varied, a minimal recognition motif has been described for this 
Serine/Threonine kinase (S/T kinase). AKT phosphorylates the recognition motif RXRXX S/T B, 
where X is any amino acid and B represents a large hydrophobic amino acid. Interestingly, a 
minority of AKT substrates lacks this motif, suggesting other methods of regulation by AKT. Its 
phosphoregulation can be activating, as in the case of IκB kinase and the upregulation of anti-
apoptotic genes, or negative as seen in the inactivating phosphorylation of Glycogen synthase 
kinase 3 (GSK-3). Deficiencies in the PI3K-AKT signaling pathway are associated with embryonic 
sub-epidermal midline blebbing and cleft palate, as seen in the Pdgfrα mouse mutants (Fantauzzo 
& Soriano, 2014). 
Upon verifying that this mutant model was signaling through AKT phosphorylation, in 
response to Pdgfr activation by PDGF, the authors employed a phosphoproteomic approach, 
involving primary mouse embryonic palatal mesenchyme (MEPM) as a proxy for palatal shelf 
response to PDGF exposure. Upon exposure of MEPM cultures to PDGF, control and untreated 
phosphorylation targets of AKT were identified. Targets of PDGF-mediated AKT phosphorylation 
largely clustered into a small number of functional classes, with the largest class reflecting 
abnormal proliferation, potentially explaining the smaller embryonic size or importantly, the 
reduced palatal shelf size observed in Pdgfrα mutants. An additional connection emerged when 
PDGF-treated MEPMs included SPECC1L in the battery of AKT phosphorylation targets 
(Fantauzzo & Soriano, 2014). 
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 This pathway has been implicated in the regulation of β-catenin required for maintenance 
of dental mesenchyme, downstream of FGF signaling (Liu et al., 2013). FGF-PI3K-AKT signaling 
has also been implicated in the development of statoacoustic ganglia in zebrafish otic development 
(Wang et al., 2015). These works represent a very small number of studies connecting PI3K-AKT 
signaling with craniofacial development generally or palatogenesis specifically. 
 
1.5.6.1 Inhibition of apoptosis via AKT activation 
 The pro-survival functions of AKT, in inhibiting apoptosis are described extensively 
(Kennedy et al., 1999). AKT inhibits pro-apoptotic proteins such as BCL2 associated agonist of 
cell death (Bad), which reverses the pro-apoptotic signaling of BCL2 apoptosis regulator (Bcl-2) 
and BCL2-like 1 (Bcl-xl) (Matsuzaki et al., 1999). Also, AKT phosphorylation activates the 
caspase inhibitory function of X-linked inhibitor of apoptosis (XIAP), either directly or 
downstream of Nuclear factor kappa B (NF-κB) activation, which also activates XIAP (Asselin et 
al., 2001). AKT phosphorylation also inhibits transcription factor Forkhead box O3 (FOXO3a), 
which promotes the transcription of the apoptosis promoting proteins BCL2-like 11 (Bim) and 
Phorbol-12-Myristate-13-acetate-induced protein 1 (Noxa). Finally, AKT interaction with Master 
target of Rapamycin (mTOR) induces its activation of BCL2 family apoptosis regulator (MCL-1), 
a protein with anti-apoptotic activity (Schulze-Bergkamen et al., 2004). Thus, several pathways 
are activated upon AKT phosphorylation, conveying the pro-survival signals of growth factors. 
 
1.5.6.2 Functions of PI3K-AKT signaling in craniofacial development 
 The roles of PI3K-AKT signaling in EMT and other cellular processes are well-described 
(Larue et al., 2005). However, any such functions in craniofacial development generally, are rare. 
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A prominent exception comes with recent studies investigating the role of platelet-derived growth 
factor receptor alpha (Pdgfrα) upstream of PI3K-AKT signaling, in a mouse model (Fantauzzo & 
Soriano, 2014). PdgfrαPI3K/PI3K homozygous mutant mice expressing a mutated Pdgfrα that is 
unable to bind and activate PI3K show a variety of phenotypes, including smaller overall size, 
delayed fusion of the medial nasal process at E11.5-12.5 and delayed maxillary fusion at E13.5. 
Also of interest was subepidermal blebbing prominent along the facial midline, abnormal neural 
tube morphology and importantly, smaller than control anterior palatal shelves possibly due to 
decreased vertical outgrowth (Fantauzzo & Soriano, 2014). 
  
1.6 Adherens junctions  
 The establishment and maintenance of tissues requires stable cell-cell adhesion (Gumbiner, 
1996). Throughout embryogenesis the dynamic nature of these adhesions allows for cell sorting, 
polarity and the stimulation of intracellular signaling cascades with respect to the developmental 
requirements of tissues (Baum & Georgiou, 2011). One such type of adhesion, the adherens 
junction (AJ), is a multimeric complex tethering adjacent cells via homotypic binding of 
extracellular cadherin proteins. The regulation of AJ stability is a critical feature of CNCC EMT, 
as AJs must be downregulated to allow their migration away from the neural folds. 
 
1.6.1 Cellular functions of Adherens junctions: Adhesion, signaling and polarity 
 The AJ is a multimeric protein complex whose fundamental role is in maintaining cell-cell 
integrity in many tissues, especially those of a stratified epithelium (Lewis et al., 1994). The AJ is 
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thought to organize around cell-cell contacts, through the heterophilic interactions of cell-adhesion 
molecule, nectin, which initially link cells at their interface. However, nectin adhesions then show 
localization of cadherins, homophilic cell adhesion molecules which dimerize with their neighbors 
via calcium binding (Lewis et al., 1994). Thus, nectins are thought to precede and perhaps recruit 
cadherins to the developing AJ (Takai et al., 2003). Nectin interacts with Afadin, an actin-binding 
protein, potentially explaining the first steps in establishing the linkage between the AJ and the 
actin cytoskeleton (Takahashi et al., 1999). Ultimately, the maturing AJ recruits alpha catenin, 
which is also an actin binding protein. Alpha catenin serves as the intermediary between the mature 
AJ and the actin cytoskeleton (Yap et al., 1997). The mature AJ also interacts with the microtubule 
cytoskeleton, through adaptor protein, such as CAP350. Indeed, depletion of CAP350 causes 
MDCKII cells to change from an elongated morphology to rounded, suggesting that AJ-
microtubule interactions contribute to cell polarity in a stratified epithelium (Robinson, 2015). 
 The additional critical addition to the AJ is the recruitment of beta catenin (Hartstock & 
Nelson, 2008). Beta catenin acts both in establishing the stability of the AJ, but also as the mediator 
which conveys Wnt signaling to the nucleus, organizing transcriptional co-activators to the 
promoters of Wnt target genes (Nelson & Nusse, 2004). Thus, one model includes the AJ as a 
component of Wnt signaling, as AJ-bound Beta catenin has been shown to enter into the Wnt 
signaling pathway, suggesting a shared pool of Beta catenin between adhesion and Wnt signaling 
(Kam et al., 2009). Thus, AJs effectively sequester beta catenin, as its structural role within them 





1.6.2 Regulation of Adherens junction: disassembly 
 While transcriptional regulation of cadherins is a key point in the regulation of the AJ 
(Peinando et al., 2004), regulatory recycling of these adhesions involves multiple other 
mechanisms, including ubiquitination of AJ components, targeting them for endocytic processing 
(Nanes & Kowalczyk, 2014). For example, the orphaned AJ, which has no binding partner in a 
neighboring cell, is endocytosed, upon calcium depletion in vitro (Kartenbeck et al., 1991). The 
process of cadherin endocytosis has since been associated with multiple processes both in 
embryonic development and association with disease and its misregulation (Nanes & Kowalczyk, 
2014). 
 Cadherin endocytosis regulating the AJ is initiated by the binding of adaptor proteins which 
permit their ubiquitination (Nanes 2014). Upon ubiquitination, the associated AJ is sequestered to 
an invaginating clathrin-coated pit, in preparation for endocytosis and subsequent recycling (Nanes 
& Kowalczyk, 2014). This process has relevance for multiple signaling cascades, as seen in the 
example of the fibroblast growth factor (Fgf) signaling also important to palatogenesis. FGF 
stimulation was found to induce E-cadherin internalization (Bryant et al., 2005). Other 
embryogenic patterning pathways also initiate cadherin internalization, as seen in the VEGF-
induced internalization of VE-cadherin (Gavard et al., 2006). 
 
1.6.3 The relevance of adherens junctions to embryonic craniofacial development 
 Cell polarity, a quality marked by the spatial distribution of proteins to either the apical or 
basal compartments establishes tissue architecture (Yoshida et al., 2012). AJs contribute to the 
establishment of apico-basal polarization of epithelia (Ohno 2001), which is lost during CNCC 
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delamination (Park et al., 2010) as AJs are remodeled. This polarization is also relevant to the 
interactions of the periderm and underlying MEE, in palatal shelf attachment and fusion (Yoshida 
et al., 2012). Another cell-cell adhesion present in this milieu is the tight junction (TJ). Amongst 
other functions, TJs promote cell polarization, by creating a lipid boundary restricting membrane-
associated proteins to either the apical or basal aspect of the cell (Cereijido et al., 1998). Indeed, 
this polarizing function of the TJ is patterned by AJs. The recruitment of certain cell adhesion 
molecules is facilitated by nectins, at developing cell-cell junctions, allowing apical AJs to develop 
into TJs (Takai et al., 2008). It has been shown that dissolution of the periderm layer coating the 
MEE of the palatal shelves is initiated by TGF signaling, resulting in a desquamatizing loss of 
polarity. In support of this, they showed that the localization of a cell polarity marker, GP135, as 
well as AJ components were dynamic in the periderm between E13.5 and E14.5, and were a 
response to TGF exposure, thus demonstrating a role for AJs and AJ-relative TJs in the periderm, 
during palatal shelf adhesion fusion (Yoshida et al., 2012). 
Complimenting these findings, proper Beta catenin regulation has been implicated as a 
requirement for successful lineage transition from NC to bona fide mesenchymal stem cells 
(MSCs). Beta catenin, an AJ component, mediates this transition and its dysregulation results in 
MSC populations inadequate for proper forebrain development (Choe et al., 2013).  
 
1.6.4 Modulation of adherens junctions through AKT signaling 
 As the transition from epithelial to mesenchymal cellular features requires the 
downregulation of cell-cell adhesion complexes, Adherens junctions (AJs), it is important to 
consider any roles played by AKT in this modulation. AKT performs an inactivating 
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phosphorylation of Glucose synthase kinase 3 alpha and beta (GSK3α/β) (Lee et al., 2009). 
Downstream GSK3β kinase function impacts metabolism, cell migration and other features, but is 
relevant here for its two-fold impact upon EMT. The first impact upon AJs is though transcriptional 
regulation of genes required for EMT, via Snail family transcriptional repressor 1 (Snail 1). Snail 
1 represses expression of the E cadherin gene, important in neural crest development due to the 
requirement of EMT during CNCC delamination from the neural folds (Cano et al., 2000). 
However, GSK3β counteracts the transcriptional changes of Snail 1, interrupting EMT 
progression. 
 The other half of the GSK3β function in regulating AJs is more direct. GSK3β 
phosphorylates β-catenin involved with AJs, targeting it for degradation by the β-catenin 
destruction complex. As a component of this protein complex, GSK3β participates in executing 
the consequences of an inactive, unstimulated Wnt signaling pathway (Wu & Pan, 2010). Upon 
phosphorylation, this heteromeric protein complex facilitates the ubiquitination and subsequent 
proteasomal degradation, modulating AJs (Li et al., 2012). Thus, reduction of upstream PI3K or 
AKT signaling, in antagonizing GSK3β, affects AJ formation and degradation. This cascade, 
beginning with receptor tyrosine kinase activation by growth factors, through PI3K-AKT signaling 
and the subsequent modulation of GSK3β effectively tethers together one aspect of EMT, in the 
acquisition of a less adhesive and more mobile, mesenchymal phenotype, in response to 
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Opitz G/BBB syndrome is a heterogeneous disorder characterized by variable expression 
of midline defects including cleft lip and palate, hypertelorism, laryngealtracheoesophageal 
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anomalies, congenital heart defects, and hypospadias. The X-linked form of the condition has been 
associated with mutations in the MID1 gene on Xp22. The autosomal dominant form has been 
linked to chromosome 22q11.2, although the causative gene has yet to be elucidated. 
 
2.1.2 Methods and results 
In this study, we performed whole exome sequencing on DNA samples from a three-
generation family with characteristics of Opitz G/BBB syndrome with negative MID1 sequencing. 
We identified a heterozygous missense mutation c.1189A>C (p.Thr397Pro) in SPECC1L, located 
at chromosome 22q11.23. Mutation screening of an additional 19 patients with features of 
autosomal dominant Opitz G/BBB syndrome identified a c.3247G>A (p.Gly1083Ser) mutation 
segregating with the phenotype in another three-generation family. 
 
2.1.3 Conclusions 
Previously, SPECC1L was shown to be required for proper facial morphogenesis with 
disruptions identified in two patients with oblique facial clefts. Collectively, these data 
demonstrate that SPECC1L mutations can cause syndromic forms of facial clefting including some 




Opitz G/BBB syndrome is a genetically heterogeneous, multiple congenital anomalies 
syndrome diagnosed on the presence of characteristic clinical features. Opitz originally described 
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two separate syndromes, the BBB syndrome and the G syndrome, which were characterized by 
hypertelorism, hypospadias and variable other midline defects. Due to the clinical overlap, these 
two syndromes were later combined into one entity, Opitz G/BBB syndrome or simply Opitz 
syndrome (Cappa et al., 1987) 
Opitz syndrome is inherited in either an autosomal dominant or X linked pattern with 
multiple reported families showing male-to-male transmission (Funderburk et al., 1978 (2-7)). 
Linkage analysis of 10 families identified one locus on Xp22 and a second locus on 22q11.2.8 
Five families were linked to D22S345 on chromosome 22q11.2 with a LOD score of 3.53 at zero 
recombination. Crossover events for markers D22S421 and D22S685 placed the Opitz syndrome 
gene within the 32 cM interval at chromosome 22q11.2, bordered distally by D22S685 and 
proximally by D22S421.8 The X linked form of Opitz is associated with mutations in the MID1 
gene at chromosome Xp22.2 which encodes a microtubule-associated RING B-box coiled-coil 
domain protein (Quaderi et al., 1997). 
Opitz syndrome is a clinically heterogeneous disorder with variable expression in both the 
X-linked and autosomal dominant families, and characterized by distinctive facial features 
including hypertelorism, a prominent forehead, broad nasal bridge and anteverted nares. 
Congenital anomalies include hypospadias, cleft lip/palate, laryngealtracheoesophageal 
abnormalities, imperforate anus and cardiac defects. Developmental delay and intellectual 
disability are variable. Hypospadias and anal anomalies were found more commonly in male 
patients with MID1 mutations than in those without (So et al., 2005, Robin et al., 1996). 
Using whole exome sequencing (WES), we identified a missense mutation in SPECC1L 
segregating with the phenotype of suspected autosomal dominant Opitz in a three-generation 






and identified a second family with a novel missense mutation in SPECC1L and clinical features 
of Opitz.5 This second family also had a three-generational pedigree with the SPECC1L mutation 
segregating with the distinguishing phenotype (see figure 2.1 B). This study provides further 
evidence that Opitz is a genetically heterogeneous syndrome and that SPECC1L mutations account 
for a subset of the autosomal dominant cases. 
 
2.3 Patients and methods 
2.3.1 Patients 
2.3.1.1 Family A 
Family A presented to genetics at the Children’s Hospital of Philadelphia after the birth of 
their second child. The proband, individual III.2 (figure 2.2 A), was the second boy born to a 24-
year-old G2 mother (figure 2.2 C) and was referred to genetics for multiple congenital anomalies 
including a congenital diaphragmatic hernia (CDH), bilateral cleft lip and palate, micrognathia, 
and dysmorphic facial features. Echocardiogram and brain MRI were normal, and he required 
monitoring for right grade two vesicoureteral reflux, and possible left sided hearing loss. At 12 
months of age, his height was at the 15th centile, weight was at the 30th centile and head 
circumference was at the 85th centile. He was noted to have a prominent forehead, hypertelorism, 
broad nasal bridge, down-slanting palpebral fissures, extra ear crus bilaterally and micrognathia. 
Bilateral cleft lip had been repaired. He had truncal hypotonia with some delay of motor 
milestones, but his speech and cognition were felt to be age appropriate. 
The proband’s brother (figure 2.2 B) had a history of tracheomalacia, inguinal and 
umbilical hernias, metopic craniosynostosis, critical aortic stenosis, and subsequent poststenotic 





months of age but was not completed due to tracheomalacia and complications with intubation. 
Repair was then pursued around 20 months of age due to persistent presentation of headaches. 
Mild delays in speech acquisition were noted although cognition was appropriate for age. 
His facial features included hypertelorism, prominent forehead with prominent metopic suture 
shown in figure 2 B and in a 3D head CT in online supplementary figure, broad nasal bridge, 
widow’s peak hairline, arched eyebrows, down-slanting palpebral fissures and a vertical groove in 
the nasal tip. There was no history of hypospadias in either boy. The mother (figure 2.2 C) had a 
history of bilateral cleft lip and palate, congenital umbilical hernia and bicornuate uterus. In 
addition, she had hypertelorism, a prominent forehead, broad nasal root and repaired bilateral cleft 
lip. She reported that her mother, sister and the sister’s children all had similar facial features. 
Genetic testing to date had been uninformative and included a normal male karyotype, 
normal SNP genome-wide microarray, and MID1 sequencing and deletion/duplication testing 
negative for Opitz syndrome in both brothers. Sequencing of EFNB1 for craniofrontonasal 
dysplasia was also normal in the proband. Sequencing of GPC3 for Simpson–Golabi–Behmel 
syndrome and TGFBR1 and TGFBR2 sequencing for Loeys–Dietz syndrome were normal in the 
brother. 
 
2.3.1.2 Family B 
Family B was previously described by Judith Allanson in 1988 and is reported as Family 
1 in the Robin et al 1995 article establishing the linkage of the autosomal dominant form of Opitz 
to chromosome 22q11.2.5811 The proband, individual III.5 (figure 2.2 D; table 1), was an affected 
girl with swallowing difficulties, stridor, micrognathia, cleft palate, bilateral hearing loss, mild 
ventricular dilatation, sagittal craniosynostosis (without history of surgery), ureteral reflux, 
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umbilical hernia and cardiomegaly, thought to be secondary to chronic hypoxia. Her facial features 
included a broad prominent nasal root and bridge, mild central groove in the tip of the nose, 
prominence of the metopic suture and both parietal areas, marked widow’s peak, downslanting 
palpebral fissures, hypertelorism, posteriorly rotated ears, and a wide and poorly defined philtrum. 
The proband’s father and his four siblings were also felt to be affected based on the findings of 
megalencephaly, hypertelorism, down-slanting palpebral fissure, high broad nasal bridge, wide 
nasal base with a hooked tip, and long columella. The father was reported to have a congenital 
upper gastrointestinal obstruction. One paternal uncle had a unilateral cleft lip and palate. 
Hypospadias was not present in the father or two affected uncles. The proband’s sister had 
hypertelorism and high broad nasal bridge. 
 
2.3.2 Methods 
2.3.2.1 Exome sequencing and bioinformatics variant 
After written informed consent was obtained, genomic DNA was extracted from the 
peripheral-blood lymphocytes of the proband and both parents, and from the saliva of the affected 
brother and maternal grandmother in Family A. Exome capture was carried out for the proband 
and both parents using NimbleGen SeqCap EZ Human Exon Library V.3.0 (Roche NimbleGen, 
Madison, Wisconsin, USA), guided by the manufacturer’s protocols. In brief, the qualified 
genomic DNA was isolated from peripheral-blood samples and randomly sheared to 200–300 bp 
fragments, followed by end-repair, a-tailing and pair-end index adapter ligation. The libraries were 
subsequently clustered on the cBOT instrument, multiplexing four samples per flowcell lane and 
sequenced using pair-end reads for 101 cycles with a paired-end mode on the Illumina HiSeq2000 
following the manufacturer’s instructions (Illumina, San Diego, California, USA). Base calling 
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was performed by the Illumina CASAVA software (V.1.8.2) with default parameters. All the raw 
reads were aligned to the reference human genome (UCSC hg19) using the Burrows–Wheeler 
aligner and single nucleotide variants (SNVs) and small insertions/deletions (indels) were 
identified using the Genome Analysis Tool Kit (GATKv2.6) (Li & Durbin, 2009, DePristo et al., 
2011). The kinship coefficient was calculated between every two samples via KING to confirm 
reported relationships (Manichaikul et al., 2010). Annovar11 and SnpEff were used to functionally 
annotate the variants and to categorize them into missense, nonsense, splice-altering variants and 
coding frameshift indels, which are likely to be deleterious compared with synonymous and non-
coding variants (Wang et al., 2010, Cinqoani et al., 2012). Under autosomal dominant mode of 
inheritance, we excluded variants that: (1) were synonymous variants; (2) present in unaffected 
father; (3) had a minor allele frequency of >0.005 in 1000 Genomes Project, 6503 exomes from 
the NHLBI Exome Sequencing Project (ESP6500SI; http://evs.gs.washington.edu/EVS/) or our 
inhouse database of >1500 sequencing exomes; (4) had a conservation score GERP++ < 2; and (5) 
were predicted by SIFT/PolyPhen2 scores to be benign variants (Davydov et al., 2010, Adzhubei 
et al., 2010, Liu et al., 2011). 
 
2.3.2.2 Sanger sequencing 
Validation of the mutation candidate was performed by Sanger sequencing in all the 
available family members using the standard techniques of PCR amplicons with primer set 5′ 
CTACCAGCCCCTCACATCG 3′ and 5′ AGTTCCTGGGTAATGTGCTGT 3′. 
This study was approved by the Institutional Review Boards at The Children’s Hospital of 




2.3.2.3 Sequencing of additional patients with Opitz G/BBB 
After written informed consent was obtained, genomic DNA was extracted from the 
peripheral-blood lymphocytes of 25 additional families with clinically diagnosed Opitz syndrome. 
Six probands were found to have MID1 mutations and all probands had normal chromosomal 
microarrays. The remaining 19 probands without MID1 mutations were sequenced for SPECC1L 
mutations by Sanger sequencing for exons 1–17 with standard techniques of PCR (see online 
supplementary table S1 for primer sets). 
 
2.3.2.4 Mutagenesis 
The p.Thr397Pro and p.Gly1083Ser mutations were created in full-length in a murine 
SPECC1L-GFP expression construct, described previously (Saadi et al., 2011) using the Q5 site-
directed mutagenesis kit (NEB, Ipswich, Massachusetts, USA) according to manufacturer’s 
protocol. The p.Gln415Pro and C-terminal calponin homology domain truncated (ΔCHD) 
constructs were created previously (Saadi et al., 2011). 
 
2.3.2.5 Cell culture 
SPECC1L-GFP expression constructs containing either wildtype or Thr397Pro, 
Gly1083Ser, Gln415Pro and ΔCHD mutations were transfected into U2OS osteosarcoma cells 
(ATCC, Manassas, Virginia, USA) using Viafect (Promega, Madison, Wisconsin, USA) or 
TransIT (Mirus Bio, Madison, Wisconsin, USA) according to manufacturer’s protocol. U2OS cells 
were grown in standard DMEM supplemented with 10% fetal bovine serum (FBS). Transfections 
and immunostaining were carried out on coverslips in 24-well plates. Cells were fixed in 4% 
paraformaldehyde (PFA) for 10 min, and blocked in phosphate buffered saline (PBS) with 1% goat 
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serum and 0.1% Tween. Acetylated α-tubulin antibody (Sigma, St Louis, Missouri, USA) was 
used at 1:1000 dilution. After staining, coverslips were mounted in VectaShield containing DAPI 
(Vector Labs, Burlingame, California, USA). 
 
2.4 Results 
2.4.1 Identification of SPECC1L mutation in Family A by WES 
The WES generated a total of 50 443 SNVs and 4799 indels in the proband, 50 533SNVs 
and 4808 indels in the mother and 50 592 SNVs and 4811 indels in the father. We applied the 
filtering strategy as described in the Patients and methods section, filtering variants to exclude 
those who had a minor allele frequency (MAF) >0.5% or predictive of benign variant. Of these, 
27 variants (see online supplementary table S2) were shared between the two affected patients 
(proband and mother), but not in the healthy father (figure 2.1 A). Those variants included a 
missense variant c.1189A>C (p.Thr397Pro) in SPECC1L (Mendelian inheritance in man (MIM) 
614140; NM_015330.3), which is required for proper facial morphogenesis (Saadi et al., 2011). 
The mutation was absent from 1000 Genomes Project, ESP6500SI, or additional exome 
sequencing data of over 1500 WES samples that we had previously sequenced in our inhouse 
database. Sanger sequencing of five family members, consisting of one unaffected and four 
affected individuals, confirmed its presence in proband, affected brother, mother and maternal 







2.4.2 Screening of additional patients 
To further establish the association between SPECC1L and Opitz syndrome, we sequenced 
its coding region in an additional 19 patients with features of Opitz syndrome. The sequencing 
analysis identified a heterozygous missense mutation, c.3247G>A (p.Gly1083Ser), in one proband 
(Family B); Family B has been previously linked to 22q11.2 by Robin et al.8 We tested one other 
family linked to 22q11.2 besides Family B and did not find a mutation in SPECC1L. Mutation 
screening of additional family members confirmed segregation of the mutation with the phenotype. 
The p.Gly1083Ser mutation occurs in the CHD of SPECC1L (figure 2.1 C) and predicted to be 
damaging with high probability according to the pathogenic score algorithms SIFT, Polyphen2, 
LRT and MutationTaster, and is not found in the 1000 Genomes Projects ESP6500SI or our 
inhouse database. 
 
2.4.3 Functional analysis 
Expression of SPECC1L-GFP results in stabilization of a subset of microtubules (figure 
3A) that appear in a lattice-like pattern and colocalize with acetylated α-tubulin (figure 2.3B, C), 
as previously described.20 We used this property of SPECC1L as a functional assay to assess the 
effect of SPECC1L Thr397Pro and Gly1083Ser mutations. Both Thr397Pro-GFP (figure 2.3D–F) 
and Gly1083Ser-GFP (figure 2.3G–I) mutant proteins show a drastic reduction in their ability to 
stabilize microtubules, consistent with these variants being pathological. The altered expression 
pattern of both Thr397Pro-GFP and Gly1083Ser-GFP mutant proteins is similar to that of the 
previously described Gln415Pro mutation (figure 2.3J–L). All three mutant SPECC1L-GFP 
proteins show a largely punctate expression pattern with poor, non-contiguous association with 
stabilized microtubules, in contrast to a robust, elaborate network of stabilized microtubules seen 
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with wildtype SPECC1L-GFP. Interestingly, while Gln415Pro and Thr397Pro lay in the second 
coiled-coil domain, the Gly1083Ser mutation is located in the C-terminal CHD which was also 
previously shown to be required for SPECC1L stabilization of microtubules (figure 2.3M–O).20 
Synthetic mutations outside these domains do not strongly affect microtubule stabilization (data 
not shown). Thus, mutations affecting the second coiled-coil domain or the CHD are likely to 
affect the same aspect of SPECC1L function and result in similar phenotypes. 
 
2.5 Discussion 
Here we report mutations in SPECC1L as a cause of autosomal dominant Opitz syndrome 
in a subset of patients. WES analysis identified a novel mutation in SPECC1L on chromosome 
22q11.23 to be the most probable disease causing mutation in a family with features suggestive of 
autosomal dominant Opitz syndrome. Sanger sequencing confirmed this result and the mutation 
was found to segregate with the clinical findings in three generations. Gene sequencing in 19 
additional patients with suspected autosomal dominant Opitz syndrome revealed one additional 
novel mutation which segregated with the phenotype in a three-generation pedigree. Importantly, 
the SPECC1L gene, located at chromosome 22q11.23, is within one Mb of the D22S345 marker, 
which was previously linked to autosomal dominant Opitz syndrome.8 From Robin et al, we tested 
two families that were linked to 22q11.2; the other family did not have a mutation in SPECC1L, 
which may be due to locus heterogeneity associated with autosomal dominant Opitz syndrome or 
due to a mutation in a non-coding area of the SPECC1L not captured by our analysis such as a 
promoter region or intron. Interestingly, there have been case reports of patients with the Opitz 
syndrome phenotype and 22q11.2 deletions (McDonald 1995, Fryburg et al., 1996, Lacassie et al., 





with 22q11.2 deletion syndrome. Further study is needed to inquire whether there are other Opitz 
syndrome causing genes on chromosome 22. 
The SPECC1L gene was first identified by Saadi et al (2011) to be disrupted by a balanced 
translocation, t(1;22)(21.3;q11.23) in a female patient with bilateral oromedial-canthal (Tessier 
IV) clefts, cleft palate, bilateral ocular hypoplasia and unilateral calcaneovarus foot deformity. The 
coding regions of SPECC1L were subsequently sequenced in 23 patients with oblique facial clefts 
and a de novo missense mutation, c.1244A>C (p.Gln415Pro), was identified in one individual 
(Saadi 2011). This mutation is located within the second coiled-coil domain of the SPECC1L 
protein, similar to the c.1189A>C (p.Thr397Pro) identified in Family A of this report. 
SPECC1L gene encodes a ‘cross-linking’ protein that functionally interacts with both 
microtubules and the actin cytoskeleton and is necessary for cell adhesion and migration (Saadi 
2011) Morpholino-based knockdown of a SPECC1L ortholog in zebrafish (specc1lb) results in 
loss of mandible and bilateral clefts between median and lateral elements of the ethmoid plate, 
which are structures analogous to the frontonasal process (FNP) and the paired maxillary processes 
(MxP), respectively (Gfrerer et al., 2014). Lineage tracing analysis revealed that cranial neural 
crest cells contributing to the FNP fail to integrate with the MxP populations, while cells 
contributing to lower jaw structures were able to migrate to their destined pharyngeal segment but 
failed to converge to form mandibular elements (Gfrerer et al., 2014). The function of SPECC1L 
in migration and adhesion of FNP and MxP is consistent with our patient phenotypes of 
hypertelorism and orofacial clefting. It is unclear why mutations in SPECC1L, and even the same 
domain, result in the two distinct phenotypes of Opitz syndrome and oblique facial clefts. Although 
facial malformations are major portions of the phenotype in both conditions, a larger cohort of 
patients with SPECC1L mutations will be needed to examine genotype–phenotype correlation. 
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Saadi et al (2011) demonstrated that the c.1244A>C (p.Gln415Pro) mutation identified in 
the patient with oblique facial cleft significantly interfered with the ability of SPECC1L to bind to 
and stabilize microtubules in an in vitro cell assay. Similarly, the Thr397Pro-GFP mutant protein 
(Family A) and Gly1083Ser-GFP (Family B) mutant proteins show a drastic reduction in their 
ability to stabilize microtubules. It is important to note that the p.Thr397Pro and the p.Gln415Pro 
mutations are both located in the second coiled-coil domain and manifest a similar inability in 
microtubule stabilization. In contrast, the p.Gly1083Ser mutation is located in the CHD, located 
at the C-terminus, which has been shown to facilitate actin binding (Saadi et al., 2011). However, 
Saadi et al (2011) demonstrated that expression of a truncated form of SPECC1L protein lacking 
the CHD (SPECC1L-ΔCHD) completely abolished the formation of stabilized microtubules as 
well. Thus, the second coiled-coil domain and the CHD interaction with actin cytoskeleton are 
required for microtubule stabilization function of SPECC1L. It is therefore consistent that the two 
mutations we report here, in the second coiled-coil domain and the CHD respectively, manifest 
similar patient phenotypes. 
The combination of hypertelorism, facial cleft and CDH has previously been reported in 
Opitz G/BBB with MID1 mutation as well as in other craniofacial disorders with midline defects 
including craniofrontonasal dysplasia with EFNB1 mutation and Simpson–Golabi with GPC3 
mutation (Taylor et al., 2010, Brooks et al., 2002, Slavotinek, 2007). Many of the other genes 
associated with CDH, including EFNB1, GPC3 and SLT3, have been found to be critical to cell 
migration (Slavotinek, 2007). Given SPECC1L’s involvement in cell adhesion and migration, it is 
therefore reasonable to speculate that the SPECC1L mutation might also explain the CDH seen in 
the proband of Family A. 
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MID1 and SPECC1L mutations result in Opitz syndrome and both of their gene products 
are involved in microtubule stability. Using the green fluorescent protein (GFP) as a tag, MID1 
has been shown to be a microtubule-associated protein that affects microtubule dynamics in MID1 
overexpressing cells (Schweiger et al., 1999). The MID1 protein consists of a tripartite motif at 
the N-terminal which includes a RING finger, two B-boxes, and a coiled-coil domain. The C-
terminus has a fibronectin Type III domain, a cells (simian CV-1) in origin, and carrying the 
Simian virus 40 (SV40) (COS) domain and a B30.2 domain Short 2006). Most mutations in X 
linked Opitz syndrome are found in the C-terminus domains and when these mutations are 
introduced into in vitro cellular assays, they abolish microtubule association of these proteins 
(Schweiger et al., 1999). It is clear that mutations in MID1 and SPECC1L have a similar cellular 
and clinical phenotype. 
The two families presented in this report show many of the classic features associated with 
Opitz syndrome, but also show some unusual features. The brother of the proband in Family A 
had surgical repair of metopic craniosynostosis and the original proband in Family B was reported 
to have a prominent metopic ridge and sagittal craniosynostosis, which were not surgically 
repaired. A detailed history of the sagittal craniosynostosis documented in Allanson’s 1988 paper 
(Allanson, 1988) in the proband in Family B and why it was not surgically repaired was difficult 
to ascertain, making further natural history studies important to further clarify the significance of 
this finding. Synostosis of the cranial sutures is not a common feature of Opitz and the presence 
of this finding may help distinguish cases caused by SPECC1L mutations, especially hypertelorism 
associated with metopic synostosis as this type of synostosis usually results in hypotelorism (see 
online supplementary figure). Hypospadias is a common finding in both autosomal dominant and 
X linked Opitz G/BBB syndrome (So et al., 2005) but was not seen in any of the affected male 
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patients in either family in this report. Therefore, absence of hypospadias in a family with 
suspected autosomal dominant Opitz syndrome should also lead a clinician to consider the 
possibility of SPECC1L mutation. Further studies are indicated to determine the prevalence of 






















Table 2.1. Prevalence of phenotypic features in patients with MID1 mutations compared with 





AIII.2 AIII.1 AII.2 BIII.5 BII.6 
Sex M M F F M 
Relationship Index Brother Mother Index Father 
Phenotypic feature:  
Facial features       
  Ocular hypertelorism +++ + + + + + 
  Prominent forehead ++ + + + + + 
  Widow’s peak ++ - + - + + 
  Broad nasal bridge ++ + + + + + 
  Anteverted nares ++  - - +  
  Micrognathia + + + + +  
  Down-slanted papebral fissures + + + + + + 
  Central groove in nasal tip  - + - +  
  Posteriorly rotated ears  - -  + + 
LTE anomalies +++ - + - +  
Hypospadias +++ - - N/A N/A - 
Cleft lip or cleft palate ++ + - + + - 
Congenital heart defect ++ - AS -   
Imperforate or ectopic anus ++ - - -   
Midline brain defects ++ -     
Diaphragmatic hernia + + - - -  
Umbilical / inguinal hernia + + + + +  
Craniosynostosis  - Metopic - Sagittal  
Hearing loss  ?   +  
Developmental delay ++ Mild Mild - Mild  
Intellectual disability ++ - - - - - 












   









   
+++ major feature, ++ minor features; * previously reported/present in patient. 
AS, aortic stenosis; GI, gastrointestinal; LET, laryngealtracheoesophageal; BU; bicornuate uterus, HT; 



















SPECC1L DEFICIENCY RESULTS IN INCREASED ADHERENS JUNCTION STABILITY 
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Cranial neural crest cells (CNCCs) delaminate from embryonic neural folds and migrate to 
pharyngeal arches, which give rise to most mid-facial structures. CNCC dysfunction plays a 
prominent role in the etiology of orofacial clefts, a frequent birth malformation. Heterozygous 
mutations in SPECC1L have been identified in patients with atypical and syndromic clefts. Here, 
we report that in SPECC1L-knockdown cultured cells, staining of canonical adherens junction 
(AJ) components, β-catenin and E-cadherin, was increased, and electron micrographs revealed an 
apico-basal diffusion of AJs. To understand the role of SPECC1L in craniofacial morphogenesis, 
we generated a mouse model of Specc1l deficiency. Homozygous mutants were embryonic lethal 
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and showed impaired neural tube closure and CNCC delamination. Staining of AJ proteins was 
increased in the mutant neural folds. This AJ defect is consistent with impaired CNCC 
delamination, which requires AJ dissolution. Further, PI3K-AKT signaling was reduced and 
apoptosis was increased in Specc1l mutants. In vitro, moderate inhibition of PI3K-AKT signaling 
in wildtype cells was sufficient to cause AJ alterations. Importantly, AJ changes induced by 
SPECC1L-knockdown were rescued by activating the PI3K-AKT pathway. Together, these data 
indicate SPECC1L as a novel modulator of PI3K-AKT signaling and AJ biology, required for 
neural tube closure and CNCC delamination. 
 
3.2 Introduction 
Cranial neural crest cells (CNCCs) are specified in the dorsal neuroectoderm and 
delaminate from the neuroepithelium of the developing neural folds through a process that involves 
epithelial-mesenchymal transition (EMT) (Le Dourain, 1982, Saint-Jeannet, 2006, Trainor, 2014). 
Premigratory epithelial CNCCs break down their cell-cell junctions and become migratory 
mesenchymal CNCCs, which populate the first and second pharyngeal arches, and give rise to the 
majority of craniofacial cartilage. Thus, genes that modulate CNCC function are frequently 
perturbed in the etiology of craniofacial congenital malformations such as orofacial clefts (Trainor, 
2014, Cordero et al., 2011, Bolande, 1997, Mangold et al., 2011, Minoux & Rijli, 2010), which 
are among the most frequent birth malformations affecting 1/800 births in the U.S. alone (Dixon 
et al., 2011). 
CNCC delamination occurs simultaneously with anterior neural tube closure between 
mouse embryonic days 8.5 and 9.5. Many mouse mutants of genes associated with orofacial clefts 
62 
 
also manifest some form of neural tube defects, including Irf6 (Ingraham et al., 2006, Peyrard-
Janvid et al., 2014), Grhl3 (Peyrard-Janvid et al., 2014), Cfl1 (Harris & Tepass, 2010) and Pdgfra 
(Fantauzzo & Soriano, 2014). However, the neural tube closure and CNCC delamination processes 
can be considered independent since the Splotch (Pax3) mouse mutant shows neural tube closure 
defects without any effect on CNCC delamination or migration (Copp et al., 2003, Murdoch & 
Copp, 2010). Additional mouse models with defects in CNCC delamination and neural tube 
closure will help delineate the shared molecular underpinnings of these two processes. 
Delamination of CNCCs from the neural epithelium requires dissolution of adherens 
junctions (AJs), composed of a protein complex, containing E-cadherin, β-catenin, α-E-catenin 
and α-actinin among others, tethered to actin filaments2. Studies where E-cadherin is 
overexpressed in the neural folds, show reduced or delayed delamination of CNCCs. Conversely, 
down-regulation of E-cadherin results in early delamination (Taneyhill, 2008, Theveneau & 
Mayor, 2012). Many factors that mediate EMT during CNCC delamination are transcription 
factors (AP2α, Id2, FOXD3, SNAIL, TWIST, SOX10) and extracellular matrix (ECM) remodeling 
proteins such as matrix metalloproteases (MMPs), however, direct cytoskeletal regulators of 
CNCC AJs are not yet known. The PI3K-AKT pathway is known to antagonize E-cadherin levels, 
primarily from cancer studies (Laure et al., 2005). Recent studies show that loss of murine PDGFα 
based PI3K-AKT signaling leads to craniofacial malformations including cleft palate and neural 
tube defects (Fantauzzo & Soriano, 2014). However, a link between the PI3K-AKT pathway and 
AJ stability in CNCC delamination is not clear. 
Previously, we identified SPECC1L as the first gene mutated in two individuals with a 
severe cleft that extends from the oral cavity to the eye, termed Oblique Facial Cleft (ObFC) or 
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Tessier IV clefts (Saadi et al., 2011). SPECC1L mutations have since been identified in two multi-
generation families with autosomal dominant Opitz G/BBB syndrome (OMIM #145410), where 
affected individuals manifest hypertelorism and cleft lip/palate (Kruszka et al., 2014), and in a 
family with Teebi hypertelorism syndrome (OMIM #145420) (Bhoj et al., 2015). More than half 
of Opitz G/BBB syndrome cases are X-linked (OMIM #300000), caused by mutations in MID1 
gene (So et al., 2005), which encodes a microtubule-associated cytoskeletal protein (Short & Cox 
2006). We proposed that SPECC1L, also a microtubule and actin cytoskeleton-associated protein, 
may mediate transduction of signals required to remodel the actin cytoskeleton during cell 
adhesion and migration (Saadi et al., 2011). Using in vitro and in vivo studies, we now describe 
SPECC1L as a novel regulator of AJ stability through PI3K-AKT signaling. At the cellular level, 
SPECC1L deficiency resulted in reduced levels of pan-AKT protein and increased apico-basal AJ 
dispersion, which was rescued by chemical activation of the AKT pathway. In vivo, Specc1l-
deficient embryos showed neural tube closure failure and reduced CNCC delamination. Thus, 
SPECC1L functions in the highly-regulated cell adhesion based signaling required for proper 
CNCC function during facial morphogenesis. 
 
3.3 Materials and Methods 
 
3.3.1 Cell lines and antibodies 
U2OS osteosarcoma control and SPECC1L-kd cells were previously described (Saadi et 
al. 2011). Anti-SPECC1L antibody was also previously characterized (Saadi et al. 2011). 
Antibodies against β-catenin (rabbit; 1:1000; Santa Cruz, Dallas TX) (mouse; 1:1000; Cell 
Signaling Technology, Danvers, MA), Myosin IIb (1:1000; Sigma-Aldrich, St. Louis, MO), E-
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cadherin (1:1000; Abcam, Cambridge, MA), AP2A (1:1000; Novus Biologicals, Littleton, CO), 
SOX10 (1:1000; Aviva Systems Biology, San Diego, CA), DLX2 (1:1000; Abcam, Cambridge, 
MA), phospho-Ser473-AKT (1:1000; Cell Signaling Technology, Danvers, MA), pan-AKT 
(1:1000; ThermoFisher Scientific, Waltham, MA), KI67 (1:1000; Cell Signaling Technology, 
Danvers MA), cleaved Caspase 3 (1:1000; Cell Signaling Technology, Danvers, MA), and β-actin 
(1:2500; Sigma-Aldrich, St. Louis, MO) were used as described. Actin filaments were stained 




3.4.1 SPECC1L is localized at cell boundaries in cultured cells upon confluency 
To characterize the role of SPECC1L at the cellular level, we used the SPECC1L-deficient 
U2OS osteosarcoma stable cell line described previously (Saadi et al., 2011). These stable 
SPECC1L-knockdown (kd) U2OS cells have a moderate (60–70%) reduction in SPECC1L 
transcript and protein levels with defects in migration and actin cytoskeleton reorganization (Saadi 
et al., 2011). In contrast, a severe transient reduction in SPECC1L has been shown to cause mitotic 
defects (Mattison et al., 2011). Upon further characterization, we find that our stable SPECC1L-
kd cells changed morphology upon very high confluency (Fig. 3.1). Individual control and kd cells 
at low confluency appeared similar (Fig. 3.1A, D). Twenty-four hours after confluency, control 
cells maintained their cuboidal shape (Fig. 3.1B, E), while SPECC1L-kd cells elongated (Fig. 
3.1C, F). The extent of this cell shape change was captured by in vivo live-imaging of control and 
kd cells (Supplemental Movie 3.1). To determine the role of SPECC1L in confluent cells, we first 
examined its expression. We found that SPECC1L protein level was increased upon confluency 





Furthermore, SPECC1L protein accumulated at cell-cell boundaries with increasing cell density 
(Fig. 3.2A–E), in a pattern overlapping with that of membrane-associated β-catenin (Fig.3. 2A’–
E’). Given the association of SPECC1L with actin cytoskeleton (Saadi et al., 2011, Mattison et al., 
2011), we hypothesized that SPECC1L interacts with actin-based adherens junctions (AJs). 
 
3.4.2 SPECC1L-kd cells show altered apico-basal dispersion of AJ proteins 
Next, we sought to determine the effects of SPECC1L deficiency on AJs. We used several 
markers associated with AJs, including canonical components F-Actin, Myosin IIb, β-catenin, and 
E-cadherin (D’Souza-Schorey, 2005, Stepniak et al., 2009, Nishimura & Takeichi, 2009, Strobl-
Massulla & Bronner, 2012). As previously reported, actin stress fibers were increased in 
SPECC1L-kd cells (Fig. 3.3A, B) (Saadi et al., 2011). Myosin IIb, associated with actin filaments, 
showed a similar increase in SPECC1L-kd cells in vitro (Fig. 3.3C, D). AJ-associated β-catenin, 
which binds to cadherins at the cell membrane, showed a normal “honey-comb” pattern of 
expression in control cuboidal cells (Fig. 3.3E, G). Interestingly, in planar images using confocal 
microscopy, β-catenin (Fig. 3.3E, F) and E-cadherin (Fig. 3.3G, H) staining at the cell membrane 
in confluent SPECC1L-deficient cells showed a drastically expanded staining pattern. This 
expansion in AJ-associated β-catenin staining in kd cells was most evident upon confluency, but 
appeared to precede the cell shape change (Fig. 3.2 F–J, F’–J’). To determine the physical nature 
of this expanded AJ staining, we examined the cell boundaries in the apico-basal plane of 
SPECC1L-kd U2OS cells (Fig. 3.3I, J) using transmission electron microscopy (TEM). Compared 
to control cells (Fig. 3.3I), which had distinct electron-dense regions indicating AJs (arrowheads), 








dispersion of AJs along the apico-basal plane. Also, in lateral sections, we observed widespread 
ruffling of the cell membrane in the kd cells (Fig. 3.9A, B), accounting for the expanded striated 
pattern of β-catenin and E-cadherin staining (Fig. 3.3F, H). In support of a role for SPECC1L in 
AJs, β-catenin co-immunoprecipitated with SPECC1L in lysates from confluent U2OS cells (Fig. 
3.3K). Together with expanded immunostaining of AJ markers, the TEM analysis is consistent 
with our hypothesis that SPECC1L deficiency increased apico-basal density and dispersion of AJs. 
 
3.4.3 Specc1l deficiency shown neurulation defect and reduced CNCC delamination 
To understand the role of SPECC1L in craniofacial morphogenesis, we created a mouse 
model of Specc1l deficiency using two independent gene-trap ES cell lines - DTM096 and 
RRH048 (BayGenomics, CA), which trap Specc1l transcripts in introns 1 and 15 respectively (Fig. 
3.4A, Fig. 3.10A, B). Genomic location of gene-trap vector insertion was identified by whole-
genome sequencing and verified by PCR (Fig. 3.10, C, D). Both gene-trap constructs also afford 
in-frame Specc1l-lacZ reporter fusion upon trapping. Thus, lacZ expression, as determined by X-
gal staining, was used as a proxy for Specc1l expression. Both alleles show a similar lacZ 
expression pattern with the DTM096 gene-trap in intron 1 showing stronger expression than 
RRH048 in intron 15 (not shown). Specc1l is expressed broadly, however, expression is 
particularly robust in the neural folds at E8.5 (Fig. 3.4B), the neural tube and facial prominences 
at E9.5 and E10.5 (Fig. 3.4C, D), and in the developing limbs and eyes at E10.5 (Fig. 3.4D). We 
previously reported that SPECC1L expression in the first pharyngeal arch at E10.5 is present in 
both the epithelium and the underlying mesenchyme (Saadi et al., 2011), consistent with CNCC 
lineage. To validate expression of SPECC1L in CNCCs, we co-stained for SPECC1L and NCC 






(Fig. 3.4K–P). At E8.5, SPECC1L stains the neural folds broadly (Fig. 3.4E, H), including cells 
stained with the NCC markers (Fig. 3.4G, J). At E9.5, SPECC1L (Fig. 3.4K, N) strongly stains 
migratory CNCCs co-stained with AP2A (Fig. 3.4L, M) or SOX10 (Fig. 4O, P). 
Intercross matings between Specc1lDTM096/+ and Specc1lRRH048/+ heterozygous mice showed 
that the two gene-trap alleles failed to complement each other, and that compound heterozygous 
and embryos homozygous for either gene trap allele are embryonic lethal (Table 3.1). The 
Mendelian ratios indicate reduced survival of heterozygotes at birth (1.34 vs. 2.0 expected). We 
noted a low incidence of perinatal lethality in heterozygotes; some with craniofacial malformations 
(Fig. 3.11, E). However, the low penetrance of these perinatal craniofacial phenotypes makes it 
difficult to study the underlying pathophysiological mechanism. Therefore, we focused on the 
embryonic lethal phenotype of the Specc1l homozygous mutant. 
The majority of Specc1lDTM096/RRH048compound heterozygous or homozygous mutant 
embryos failed to thrive beyond E9.5–10.5 (Fig. 3.5A–D), with a failure of the neural tube to close 
anteriorly (Fig. 3.5B, D), and sometimes posteriorly (not shown). This cranial neural tube closure 
defect was accompanied by a large proportion of CNCCs, marked by DLX2, to remain in the 
neural folds at E10.5, suggesting a failure to delaminate (Fig. 3.5A’–D’). To determine if there 
was also a reduction in overall specification of CNCCs, we marked the CNCC lineage with GFP 
in our gene-trap lines with Wnt1-Cre and ROSAmTmG. We flow-sorted the GFP+ NCCs and GFP- 
(RFP+) non-NCCs from whole embryos. At E9.5, the proportion of flow-sorted GFP-labeled 
CNCCs did not change significantly between WT and mutant embryos (not shown), indicating 
normal CNCC specification. Thus, we hypothesized that the residual staining with Wnt1-Cre and 







due to increased density or dispersion of AJs, as observed in SPECC1L-kd cells. We used NCC 
markers SOX10, AP2A, and DLX2 to confirm the presence of CNCCs in the neural folds (Fig. 
3.5E–R). At E8.5, neural fold staining is observed with all three NCC markers in both WT (Fig. 
3.5E, G, I) and Specc1l mutant (Fig. 3.5F, H, J) sections. At E9.5, while NCC markers stain 
migratory NCCs in WT sections (Fig. 3.5M, O, Q), residual NCC staining is present in the open 
neural folds of Specc1l mutant embryos (Fig. 3.5N, P, R). Since SOX10 and DLX2 mark migratory 
CNCCs, this result indicates that SPECC1L deficient CNCCs attain post-migratory specification 
but fail to emigrate from the neural folds. 
 
3.4.4 Specc1l mutant tissue recapitulates in vitro adherens junction changes 
To test our hypothesis that reduced delamination is due to altered AJs, we investigated the 
AJ markers in the open neural folds of Specc1l mutant embryos (Fig. 3.5S–Z). We observed 
increased actin stress fibers (Fig. 3.5S, T) and concomitant increased localization of Myosin IIB 
staining to the actin fibers (Fig. 3.5U, V). Importantly, we saw increased staining of β-catenin (Fig. 
3.5W, X) and E-cadherin (Fig. 3.5Y, Z) at cell-cell boundaries. We also examined β-catenin 
staining of NCCs in the neural folds of E8.5 embryos (Fig. 3.5K, L). The β-catenin staining appears 
more robust in Specc1l mutant neural folds (Fig. 3.5L vs. K), suggesting that changes in AJs have 
commenced. In electron micrographs of cranial sections from E9.5 embryos, we again observed 
an increase in dispersed electron-dense staining in Specc1l mutant embryos compared to WT (Figs 
3.5AA, BB and 3.9, E–H). Taken together, these results validate our in vitro findings in SPECC1L-





3.4.5 Reduced PI3K-AKT signaling and increased apoptosis in SPECC1L deficient cells 
Given the known antagonistic relationship of AKT activity to E-cadherin stability (Larue 
et al., 2005, Thomas-Tikhonenko, 2010), we hypothesized involvement of PI3K-AKT signaling. 
In addition, we observed sub-epidermal blebbing in some of our mutant embryos that escape E9.5–
10.5 lethality (<5%), and instead arrest at approximately E13.5 (Fig. 3.11). Sub-epidermal 
blebbing is a hallmark of reduced PDGFRα-based PI3K-AKT signaling (Fantauzzo & Soriano, 
2014). Fantauzzo et al. (2014) reported that disruption of PDGFRα-based PI3K activation in 
PdgfraPI3K/PI3K mutant embryos results in sub-epidermal blebbing, neural tube defects, and cleft 
palate phenotypes. Indeed, pan-AKT and active phospho-Ser473-AKT levels were reduced in vivo 
in Specc1l mutant tissue (Fig. 3.6A–D), prior to embryonic arrest at E9.5. Reduced phospho-
Ser473-AKT level was likely entirely due to reduced pan-AKT levels in vivo (Fig. 3.6E) and in 
vitro (Fig. 3.6F). The in vitro reduction was only present at high confluency of U2OS cells upon 
cell shape and AJ density changes (Fig. 3.6D). Thus, our data suggest SPECC1L is a novel positive 
regulator of PI3K-AKT signaling in craniofacial morphogenesis. 
We next examined markers of proliferation and apoptosis. We did not observe any 
differences in proliferation in E9.5 embryos (Fig. 3.6E, G vs. I) as measured by KI67 staining, 
with a proliferative index of 82.5% for WT and 86.5% for Specc1l mutant (p < 0.56, Fisher exact 
test). Similarly, we did not observe any difference in apoptosis as measured by cleaved Caspase 3 
staining in neural folds at E8.5, prior to embryonic arrest (not shown). In contrast, apoptosis was 
markedly increased throughout the E9.5 mutant embryo (Fig. 3.6F, H vs. J). This global increase 
in apoptosis is consistent with reduced PI3K-AKT signaling and early embryonic lethality (Zeitlin 





3.4.6 Upregulation of PI3K-AKT pathway rescues SPECC1L-kd phenotype 
Next, to confirm a causal role for PI3K-AKT signaling in AJ change in our kd cells, we 
chemically altered the pathway in control and kd cells (Fig. 3.7A–F). We used the cell shape 
change phenotype observed in confluent SPECC1L-kd cells as a marker, which we quantified 
using the ratio of the longest dimension (length) and the corresponding perpendicular dimension 
(width). A relatively round or cuboidal cell would be expected to give a ratio of 1 (Fig. 3.7G). In 
addition to cell shape, we confirmed the effect on AJs through β-catenin staining (Fig. 3.7A’–F’). 
Inhibition of the PI3K-AKT pathway using Wortmannin was sufficient to alter cell shape (Fig. 
3.7A, C) and AJs (Fig. 3.7A’) in control cells. The PI3K-AKT activator, SC-79, did not affect cell 
shape (Fig. 3.7A, E) or AJ expansion (Fig. 3.7A’) in control cells. In SPECC1L-kd cells, further 
down-regulation of PI3K-AKT pathway resulted in increased apoptosis (Fig. 3.7B, D) with 
drastically expanded staining for β-catenin (Fig. 3.7B’), consistent with our severe mutants in vivo. 
Importantly, upregulation of the PI3K-AKT pathway drastically ameliorated the cell shape (Fig. 
3.7B, F) and AJ (Fig. 3.7B’’) phenotypes. As stated above, changes in cell shape were quantitated 
as a cell circularity ratio (CCR), and compared for significance (Fig. 3.7G). Indeed, in control cells 
(Fig. 3.7G, CCR = 1.56), Wortmannin treatment was sufficient to significantly change cell shape 
(Fig. 3.7G, CCR = 3.61, p < 2.4 × 10−9), which was similar in extent to that seen in SPECC1L-kd 
cells (Fig. 3.7G, CCR = 3.46). Wortmannin treatment of SPECC1L-kd cells (Fig. 3.7G, 
CCR = 3.60, not significant) did not affect cell elongation any further than untreated kd cells (Fig. 
3.7G, CCR = 3.46, not significant) or Wortmannin-treated control cells (Fig. 3.7G, CCR = 3.61, 
not significant). Most important, SC-79 AKT activator rescued the elongated cell shape phenotype 







SPECC1L regulates PI3K-AKT signaling, and indicate that moderate reduction in SPECC1L 
affects cell adhesion, while severe reduction can lead to apoptosis (Fig. 3.8). 
3.5 Discussion 
Dissolution of AJs is required for pre-migratory CNCCs to delaminate from the neural 
epithelium of the anterior neural folds (Le Douarin, 1982, Taneyhill, 2008, Theveneau & Mayor, 
2011). The increased staining of AJ components and loss of apico-basal asymmetrical distribution 
of AJs in SPECC1L-deficient cells in vitro and in vivo, combined with physical proximity of 
SPECC1L with β-catenin indicates a role for SPECC1L in maintaining localized stability of AJs 
by properly organizing the actin cytoskeleton. The association of SPECC1L with the actin 
cytoskeleton and β-catenin combined with an increase in condensed actin filaments upon 
SPECC1L deficiency are consistent with the observed increase in AJ density. Another possibility 
is that increased actin fibers in SPECC1L deficient cells lead to altered tension between cells. As 
cell tension can impact AJ dynamics (Harris et al., 2014), a change in tension may lead to more 
dispersed AJs (Engl et al., 2014). Either alteration can consequently affect CNCC delamination. 
Wnt1 is expressed in the early neural folds that give rise to neural crest cells. Thus, Wnt1-
cre lineage tracing marks both pre-migratory and migratory NCCs (Chai et al., 2000). However, 
Wnt1 also marks lineage of dorsal brain tissues that also arise from the early neural folds (Chai et 
al., 2000, Brault et al., 2001), leaving a possibility that the Wnt1-marked staining in our E9.5 
mutant open neural folds were not CNCCs. Our positive staining with NCC markers AP2A and 
SOX10 confirms that the open neural folds of the Specc1l mutant embryos indeed contain CNCCs. 
Furthermore, since AP2A and SOX10 are markers for early migrating NCCs, the positive staining 





Our data indicate that the molecular regulation of AJs by SPECC1L is mediated by PI3K-AKT 
signaling. AKT signaling is reduced in SPECC1L-deficient cells and tissue. A direct role for PI3K-
AKT signaling in craniofacial morphogenesis is supported by the findings of Fantauzzo et al. 
(2014) showing that lack of PDGFRα-based activation of PI3K-AKT signaling leads to cleft palate 
phenotype. We also showed that inhibition of the PI3K-AKT pathway is sufficient to alter AJs and 
cell shape in U2OS cells. Consistent with our findings, Cain et al, (2010) have shown that in 
endothelial cells down-regulation of PI3K α110 subunit led to a similarly expanded pericellular β-
catenin staining, termed as increased “junctional index”. However, in their endothelial cells with 
already highly organized actin filaments, the down-regulation of PI3K-AKT pathway resulted in 
a relaxation of cell shape. In contrast, the SPECC1L-kd U2OS cells show elongated cell shape. 
This difference is likely cell-type specific. While down-regulation of PI3K-AKT signaling 
consistently affects the actin cytoskeleton, the effect on cell shape is dictated by altered tension 
resulting from changes in central actin fiber density and organization. In U2OS cells, we used the 
cell shape change only as a marker of the SPECC1L-deficient AJ change and rescue. Taken 
together, we propose that suppression of AKT pathway upon SPECC1L deficiency increases AJ 
stability and reduces delamination of the CNCCs. 
Interestingly, pan-AKT levels are reduced in addition to phospho-473-AKT levels in vitro 
and in vivo upon SPECC1L deficiency, thus indicating regulation of PI3K-AKT signaling at the 
level of AKT protein stability or turnover. Both SPECC1L and MID1 genes, implicated in 
Opitz/GBBB Syndrome, encode proteins that stabilize microtubules (Saadi et al., 2011, Short & 
Cox, 2006). The mechanism through which SPECC1L and MID1 mediate microtubule 
stabilization is not entirely clear. In the case of SPECC1L, this stabilization involves enhanced 
acetylation of a subset of microtubules (Saadi et al., 2011). Perhaps SPECC1L utilizes a similar 
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mechanism to stabilize other proteins such as AKT. Acetylation of lysine residues in AKT protein 
has been shown to result in reduced membrane localization and phosphorylation (Sundaresan et 
al., 2011). In addition, K63 chain ubiquitination of the same lysine residues on AKT is required 
for its membrane localization and activation (Yang et al., 2009, Chan et al., 2014). Of the few 
SPECC1L protein interactors identified in different high throughput yeast two-hybrid screens, 
four-CCDC8 (Hanson et al., 2014), ECM29 (Gorbea et al., 2010), APC and UBE2I 
(Bandyopadhyay et al., 2010) - participate in protein turnover or stability through ubiquitination 
or sumoylation. It is possible that SPECC1L participates in the post-translational modification of 
AKT lysine residues, affecting AKT stability. However, a definitive role for SPECC1L in AKT 
protein localization and stability is yet to be elucidated. 
A severe deficiency in SPECC1L expression in vivo results in increased AJ marker staining 
and defective CNCC delamination, as well as in increased apoptosis and early embryonic lethality. 
Previous reports have shown that mouse mutants with increased levels of apoptosis have associated 
neural tube (Homanics et al., 1995, Ikeda et al, 2001, Ruland et al., 2001, Migliorini et al., 2002) 
and craniofacial defects (Jeong et al., 2004). It is proposed that excessive cell death in the neural 
folds or pharyngeal arches may result in insufficient number of cells required for proper 
morphogenetic movement (Jeong et al., 2004, Copp, 2005, Harris & Juriloff et al., 2007). In 
contrast, our SPECC1L-deficient cell lines with moderate reduction in SPECC1L expression show 
only AJ changes without evidence of increased cell death. However, chemical inhibition of PI3K-
AKT pathway in these kd cells does indeed lead to increased apoptosis. Thus, a moderate reduction 
in SPECC1L expression or function allows cell viability. This is consistent with the observation 
that rare Specc1l mutant embryos that escape E9.5 arrest - likely due to reduced gene-trapping 
efficiency - are able to close their neural tubes and arrest later in development, frequently with 
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craniofacial defects (Fig. 3.11). Also, consistent with this is the rare occurrence of Specc1l 
heterozygous embryos with craniofacial malformation - likely due to increased gene-trapping 
efficiency - and findings in zebrafish where morphants for one of two SPECC1L orthologs 
(specc1lb) lead to late embryonic phenotypes including a loss of mandible and bilateral clefts 
(Gfrerer et al., 2014). Thus, heterozygous SPECC1L loss-of-function mutations identified in 
human patients may lead to mild perturbation in SPECC1L function during craniofacial 
morphogenesis, sufficient to account for their orofacial clefts. SPECC1L-based modulation of cell-
cell contacts may also play a role in palatogenesis and pharyngeal arch fusion. Further studies of 
SPECC1L function will help elucidate the role of transient cell-cell contacts in neuroepithelial cell 








































MODERATE DEFICIENCY OF SPECC1L IMPAIRS COLLECTIVE MIGRATION OF 











Chapter Four: Moderate deficiency of Specc1l impairs collective migration of primary 
palatal mesenchyme cells 




Mouse crosses and palatal shelf dissection was performed by EH, Cell culture was performed by 
NW, Live imaging was performed by NW and EK, cell tracking was performed by EK, JG and 
NW, computational analyses were performed by EK, GI and AC. 
 
4.1 Abstract 
Cranial neural crest cells (CNCCs) migrate from the embryonic neural folds to the 
pharyngeal arches, contributing to maxillofacial development. Collective cell migration is a 
cooperative process fundamental to embryonic development, which shapes and populates 
emerging tissues. Unlike directional migration, during which each cell acts as an independent 
player, collective migration requires dynamic relationships between members in the coordination 
of movement. The collective migration required for CNCC infiltration of the pharyngeal arches is 
relevant to the aberrant development seen in orofacial clefting, as demonstrated by deficiency of 
the tumor suppressor Merlin, one of the few known proteins which disrupts collective migration, 
Merlin mutant mice have cleft palate, among other defects (Gritli-Linde et al., 2008, Das et al., 
2015). SPECC1L-kd U2OS cells show impaired wound healing, taking longer to fill wounds than 
wildtype U2OS cells (Saadi et al., 2011). We have shown that this impairment is dependent upon 
the elongated cell shape change, which occurs in SPECC1L-kd U2OS cells (Chapter Three). The 
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extent of collective cell migration can be quantified by measurement of correlation length, which 
represents the distance from an observed cell where its neighbors continue migrating in the same 
direction as it (Szabó et al., 2010). Here we report that SPECC1L-kd U2OS cells show reduced 
correlation lengths when compared with wild type counterparts, indicating a defect in collective 
migration. Compound mutant mice harboring severe gene trapped Specc1lRRH/- and hypomorphic 
deletion Specc1lΔ300/- alleles (Specc1lRRH/Δ300) show incompletely penetrant CP. Wound assays 
using wild type and Specc1lRRH/300 embryonic palatal mesenchyme cells (MEPM) showed a 
comparable reduction in correlation length, indicating defects in collective migration. Previously, 
we reported that these U2OS SPECC1L-kd cells exhibit adherens junction and morphological 
phenotypes due to downregulation of PI3K-AKT signaling pathway. We report that the delayed 
wound closure time seen in SPECC1L-kd U2OS cells is partially rescued by AKT activation, in 
vitro. Together, these data indicate SPECC1L as a novel modulator of the functions of PI3K-AKT 
signaling in CNCC migration. 
 
4.2 Introduction 
 CNCCs, differentiating within the dorsal neuroectoderm, subsequently delaminate and 
migrate into the pharyngeal arches, where they contribute to most craniofacial cartilage and bone 
(Trainor et al., 2000). However, many questions remain concerning CNCC collective cell 
migration, a process marked by cell-cell interactions (Theveneau & Mayor, 2012). 
 Frequently the disruption of genes regulating CNCC functions is associated with 
craniofacial malformations such as orofacial clefts, a common congenital deformity affecting 
approximately 1/800 live births. Of interest are genes which affect collective migration and 
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associate with facial clefting, such as Filamin A, which disrupts epithelial migration (Simpson et 
al., 2008) and is also associated with the syndromic cleft palate of Otopalatodigitial type 1 
syndrome (Passos-Bueno et al., 2009). Neural crest-specific Filamin A knockout in mouse causes 
abnormalities of the cardiac outflow tract (Feng et al., 2006). 
 Collective cell migration requires cell-cell and cell-ECM interactions (Rorth, 2009). 
Migratory CNCCs interact with each other through transient adhesions involving N-cadherin (Xu 
et al., 2001). These interactions may negate CNCC proliferation throughout migration, as cells at 
the leading edge enter mitosis more frequently than those following them. Migratory CNCCs also 
show chemotactic responses to secreted factors such as VEGF and Sdf1 (Kulesa & McLennan, 
2015), as well as other cell-environment signals including contact with Ephrins and Semaphorins, 
as well as proteoglycans (Kulesa & McLennan, 2015). 
 Proper migration, proliferation and differentiation of CNCCs are required for 
palatogenesis. The disruption of any of these processes can cause facial clefting (Ito et al., 2003). 
Previously, SPECC1L was identified as the first gene mutated in severe, atypical facial clefting 
which extend from the oral cavity to the eye, in two human patients (Saadi 2011). SPECC1L 
mutations have been identified in two families affected by autosomal dominant Opitz G/BBB 
syndrome (OMIM #145410) (Kruszka  & McLennan, 2015), which manifest cleft lip/palate. Other 
Opitz G/BBB syndrome cases are X-linked (OMIM #300000) and are caused by mutations in 
MID1, encoding a protein associated with the microtubule cytoskeleton (Schweiger et al., 1999). 
SPECC1L also interacts with both the microtubule and actin cytoskeletons. Indeed, cytoskeletal 
regulation is critical in neural crest migration, such as seen in the disruption of actin 
depolymerizing protein n-cofilin, which causes defective neural tube closure and impaired neural 
crest migration (Gurniak et al., 2004). Recently we described a role for SPECC1L in modulation 
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of the actin cytoskeleton and subsequent cell shape, through a PI3K-AKT dependent mechanism 
(Chapter Three). Specifically, SPECC1L-kd U2OS cells change from a cuboidal to an elongated 
cell shape, upon high confluence. SPECC1L-kd phenotypes also include increased apico-basal 
adherens junction (AJ) dispersion, with severe mouse mutants showing impaired delamination of 
CNCCs from the open neural folds. These phenotypes were reversible in vitro, through reactivation 
of AKT signaling by a small molecular activator, SC79, complementing our finding that severe 
mutants show reduced pan-AKT levels. 
Previously we reported the homozygous lethal phenotypes of Specc1l gene trapped mouse 
embryos. This lethality occurs prior to embryonic day 9.5 (E9.5), marked by phenotypes which 
include reduced embryonic size relative to developmental stage and importantly, failure of CNCCs 
to delaminate from the still open neural folds (Chapter Three). Thus, this severe model of 
SPECC1L deficiency prohibits the investigation of post E9.5 developmental processes. 
To expand our understanding of additional roles played by SPECC1L in CNCCs, we 
generated zinc finger deletions in Specc1l to allow modeling of less severe, moderate SPECC1L 
disruptions likely more reflective of human clefting pathogenesis. The SPECC1LRRHΔ300 mouse 
shows delayed palatal fusion in approximately 50% of embryos and frequently show sub-
epidermal blebbing associated with defects in the PI3K-AKT signaling pathway (Fantauzzo & 
Soriano, 2014). We used in vitro studies of SPECC1L-kd U2OS cultured cells and 
SPECC1LRRHΔ300 mouse-derived primary MEPM cells to demonstrate a defect in collective 
migration, as identified through reduced correlation lengths of migratory streams. We report that 
this defect is responsive to modulation of the PI3K-AKT signaling pathway, complementing our 
previous findings showing the same responsiveness to the shape and AJ changes seen in 
SPECC1L-kd U2OS cells (Chapter Three). 
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4.3 Materials and methods  
Cell lines 
U2OS osteosarcoma control and SPECC1L-kd cells were previously described (Saadi et 
al., 2011). 
 
Cell shape change in U2OS cells 
U2OS control and SPECC1L-kd cells were cultured in standard DMEM high glucose 
media supplemented with 10% fetal bovine serum (Life technologies, Carlsbad, CA). To modulate 
the PI3K-AKT pathway, cells were cultured in described concentrations of PI3K-AKT inhibitor, 
Wortmannin (TOCRIS Biosciences, Minneapolis, MN), or activator, SC-79 (TOCRIS 
Biosciences, Minneapolis, MN). Media with chemicals was replaced daily. 
 
Primary culture of mouse embryonic palatal mesenchyme (MEPM) 
Mice heterozygous for the severe Specc1l gene trap allele Specc1lRRH/- were mated with 
heterozygous mutants of the hypomorphic Specc1lΔ300/- deletion allele, yielding compound mutant 
Specc1lRRH/Δ300 embryos for primary culture. At E13.5, WT, heterozygotes and Specc1lRRH/Δ300 
embryos were harvested for excision of the palatal shelves. Subsequent incubation in Liberase DL 
(Roche, Basel, Switzerland) allowed mechanical separation of palatal shelf epithelium and 
dissolution of remaining mesenchyme into single-cell suspension. Primary MEPM cultures were 
seeded onto fibronectin treated tissue culture plastic vessels in 3D-printed rings with the same 
dimensions as one well of a standard 96 well plate. Upon overnight incubation in standard 





Time-lapse recordings were performed of live control and kd cells in regular culture 
conditions with a phase contrast image collected every 10 minutes over a period of seven days. 
Images were taken with a computer-controlled Leica DM IRB inverted microscope equipped with 
a powered stage and a 10 × N-PLAN objective, coupled to a QImaging Retiga-SRV camera. 
During imaging, cell cultures were kept at 37C in a humidified 5% CO2 atmosphere. 
 
Live-imaging analysis 
Live-imaging of U2OS cells and primary MEPM cultures were manually tracked to 
identify the position of each cell migrating into the wound, per frame, until wound closure, using 
tracking software developed at the University of Kansas Medical Center (Dr. András Czirók, 
Ph.D.). Resulting coordinate tables were then analyzed using particle image velocimetry, as 
previously described (Zamir et al., 2005) and correlation length analysis using software developed 
by Dr. András Czirók, Ph.D. 
 
4.4 Results 
4.4.1 Specc1l deficiency impairs the collective migration of U2OS cells 
 Prior work showed that SPECC1L-kd U2OS cells are defective in wound closure, 
compared to WT U2OS cells, establishing a role for SPECC1L in cell migration (Saadi et al., 
2011). Thus, we first explored which qualities of cell migration were disrupted, since embryonic 
migration, can largely be disrupted by many factors, including disruptions between individual cells 
and their neighbors (Saadoun et al., 2015), individual cells and their environment (Kulesa & 
McLennan, 2015), as well as disruption of the ability of cells to collectively migrate as a group 
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(Das et al., 2015). The latter is especially important to craniofacial development, given the 
migratory patterns they exhibit, which specifically feature formation of migratory streams, where 
each individual cell physically interacts with its neighbors, during migration (Belvindra et al., 
2007). 
Due to the functional importance that the actin cytoskeleton serves in establishing cell 
shape, we first investigated cell migration, considering the altered actin cytoskeleton and 
morphology of SPECC1L-kd cells. SPECC1L-kd U2OS alteration is density dependent. Thus, we 
performed wound healing assays, using wild type and SPECC1L-kd U2OS cell cultures, both 
before and after these changes. Interestingly, frame rate counting and kymographs derived from 
live cell imaging show wound closure rates equivalent between wild type and SPECC1L-kd U2OS 
cells, before shape change (Fig. 4.1 A). However, in cultures wounded after high density and 
subsequently altered morphology, SPECC1L-kd U2OS cells exhibited notably increased time in 
closing the wound, when compared with their wild type counterparts (Fig. 4.1 B). 
To investigate what aspect of cell migration this density-dependent change perturbs, we employed 
particle image velocimetry (PIV), an analytic method commonly employed in understanding the 
dynamics present in fields of individual objects in dynamic movement (Zamir et al., 2005). PIV 
generates coordinate tables describing the position of individual objects in motion, over time. 
These coordinates allow the calculation of correlation length, which represents how effectively 
cells are migrating in each direction, with respect to each other (Zamir 2005), and is considered a 
measurement of collective cell migration (Das et al., 2015). 
Such analyses were performed on low and high density fields, without wounds, as well as 





SPECC1L-kd U2OS cells do not show a disparity in PIV displacement which can explain the 
impaired wound closure. SPECC1L-kd cells show increased displacement upon wounds made 
before shape change and comparable displacement in wounds made after this change, showing that 
SPECC1L-kd cells have the displacement potential necessary to close wounds as quickly as their 
wild type counterparts (Fig. 4.1C). An example of such a finding can be seen when correlation 
length is reduced upon deficiency of Merlin, which is also accompanied by an increase in velocity 
(Das et al., 2015). As a difference in velocity cannot explain impaired collective migration in 
SPECC1L-kd U2OS cells, we next examined collective cell migration (Fig. 4.1D). 
Measuring the correlation lengths of migratory cell streams is a measure of collective 
migration. Correlation lengths can be assessed directionally, describing the lengths of streams of 
cells moving perpendicular or in parallel with each other (Slater et al., 2013). Correlation length 
measurements show that wild type and SPECC1L-kd cells provide similar stream lengths, in 
wounds made before cell shape change, (Fig. 4.1D, Wound 1). Wounds made after SPECC1L-kd 
induced shape change (Fig. 4.1D, Wound 2) show wild type U2OS correlation lengths do not 
change between low and high confluence. However, SPECC1L-kd cells show a notable decrease 
in correlation lengths (Fig. 4.1D, Wound 2), suggesting that defective wound healing after 
SPECC1L-kd induced shape change is due to defects in the ability of these cells to collectively 
migrate. Directional measurement of correlation lengths involving parallel and perpendicular 






4.4.2 Moderate Specc1l mutants show altered adhesion in a model of CNCC migration 
As severe deficiency of Specc1l results in an embryonic lethal phenotype prohibiting 
investigation of neural crest migration, we generated a hypomorphic Specc1l allele to allow this 
(Fig. 4.2A). The hypomorphic Specc1lΔ300/- allele generates a 57-amino acid in-frame deletion 
between coiled coil domains 5 and 6 (Fig. 4.2A), which transcribes a protein of reduced molecular 
weight detectable by Western blotting (Hall, et al., in preparation). Understanding the underlying 
hypomorphic function of this allele is work still ongoing. 
Mating of Specc1lRRH/- with Specc1lΔ300/- heterozygous mice yields compound mutant 
Specc1lRRH/Δ300 embryos which are perinatal lethal, showing incompletely penetrant (~50%) 
delayed palatal shelf elevation (Hall, et al., in preparation). We then investigated in vitro neural 
crest progenitor migration by combining these alleles on a background which genetically labels a 
cell population including neural crest progenitors, using the Wnt1-GFP marker background. Using 
established neural crest explanation technique, we investigated whether hypomorphic Specc1l 
disruption impacts migration. 
Upon excision of the neural folds from E8.5 WT, Specc1lRRH/-, Specc1lΔ300/- and 
Specc1lRRH/Δ300 mouse embryos, they were placed upon fibronectin-coated plastic, to facilitate 
adhesion and migration of Wnt1-GFP cells out of the tissue. Neural folds isolated from WT 
embryos quickly adhered to this substrate, showing adhesion and subsequent outward cell 
migration (Fig. 4.2D, upper panel). Wnt1-GFP expressing cells can be seen migrating out of the 
adhering explant, migrating away from its bulk in constant waves (Fig. 4.2D, lower panel). 
Interestingly, Specc1lRRH/300 compound mutant neural fold explants never adhered completely, 
with most never adhering long enough for analysis. The few that did adhered transiently, and 
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produced almost no Wnt1-GFP positive migratory cells (Fig 4.2E, lower panel, Supplemental 
video). 
Although visible in phase contrast, the Wnt1-GFP signal in these explants is harder to 
visualize, as the non-adhering tissue is outside of the live imaging focal plane (Fig.4.2 E). We also 
verified that neural crest induction does occur, as Wnt1-GFP expressing cells are present in the 
neural folds of Specc1lDTM/DTM mutant embryos. Additionally, fluorescence assisted cell sorting of 
embryonic lysates show that wild type and severe Specc1lDTM/DTM mutant embryos show equivalent 
proportions of Wnt1-GFP positive and negative cells (Fig.4.2 B, C). 
 
4.4.3 Wound assays show reduced collective migration in SPECC1LRRH/300  MEPMs 
 Culturing of explanted neural fold tissues was an unsuited technique to assess migration of 
CNCCs from Specc1l deficient embryos. Thus, we employed an extensively used method, primary 
culture of embryonic palatal mesenchyme, as described (Yu et al., 2005). MEPM cells were used 
as a proxy for CNCCs, as they are derived from the neural crest. MEPMs isolated from wild type 
and SPECC1LRRH/300 palatal shelves were isolated from E13.5 embryos and cultured for wound 
assays. 
Wound assays performed upon cultured wild type and SPECC1LRRH/300 MEPM cell 
cultures showed that SPECC1LRRH/300 MEPM cells show reduced speed of wound closure, as seen 
in kymographic representation of frame by frame cell movements (Fig 4.3. A, B). Like our U2OS 
displacement results (Fig. 4.1, C), SPECC1LRRH/300 MEPMs show increased displacement, as 
shown by PIV analyses of live-cell imaging (Fig 4.3, C). This increased displacement was 





higher average velocity of SPECC1LRRH/300 MEPMs, when compared with their wild type 
counterparts (Fig 4.3, D). Superficially it would seem as though cells with higher average velocity 
would be able to close a wound more rapidly and would not show a notable delay in closure time. 
However, SPECC1LRRH/300 MEPMs show reduced correlation lengths when compared with their 
wildtype counterparts (Fig 4.3, E), indicating impaired collective migration. 
 
4.4.4 Activation of AKT rescues delayed wound closure in SPECC1L-kd U2OS cells 
 Previously, we reported that severe Specc1l gene trapped mouse mutants show reduced 
pan-Akt protein level, which is independent of Akt transcription (Chapter Three). Modulation of 
the PI3K-AKT signaling cascade with molecular activators and inhibitors could rescue or 
phenocopy, respectively, the morphological and adhesive phenotypes associated with SPECC1L 
deficiency, in U2OS cells (Chapter Three). Specifically, we found that inhibition of Phosphatidyl-
inositol kinase 3 (PI3K) with Wortmannin (Abbas et al., 1998), induced in wild type U2OS cells 
an elongated morphology and an increase in the density of adherens junctions, which are the 
hallmarks of SPECC1L-kd. Additionally, we reported that activation of downstream PI3K effector 
V-Akt murine thyoma viral oncogene homolog 1 (AKT) with the small molecule modulator SC79 
(Jo et al., 2012) in SPECCC1L-kd U2OS cells rescued the elongated morphology and altered AJs. 
Thus, we next investigated the possibility that modulating PI3K-AKT signaling could also rescue 
delayed wound closure. 
 Upon examination of the number of frames required for wound closure, pretreatment of 
wild type U2OS cell cultures with Wortmannin caused a robust negative effect on wound closure 
speed seen in untreated wild type wounds (Fig 4.4 A-C’), at the same concentration (30 μM) used  





show an improvement in wound closure speed when compared with vehicle treated wound cultures 
(Fig 4D’). These experiments were conducted at the same concentration of SC79 (500 μM) 
required to rescue morphological and adhesion defects we reported previously (Chapter Three).  
Thus, we have demonstrated SPECC1L deficiency causes defects in the collective 
migration of U2OS and MEPM cells which results from a reduction in the parallel and 
perpendicular correlation lengths of migrating streams. This defect, as assessed by wound closure 
time, is rescued upon AKT activation, suggesting a common mechanism underlying this defect 
and the morphological and adhesion phenotypes. Previously, others have shown an increase in 
wound closure time correlating with AJ density, in retinal pigment epithelial cells (Kaida et al., 
2000), suggesting that SPECC1L-kd U2OS altered AJs may cause reduced wound closure. Given 
the temporal sensitivity of various aspects of tissue morphogenesis relative to collective cell 
migration, these results contribute to furthering our understanding of the link between cellular 
phenotypes and both normal and aberrant embryonic craniofacial development. 
 
4.5 Discussion 
 Collective migration of CNCCs is required for the contribution of CNCCs to the 
developing maxilla and mandible (Chai et al., 2000). The reduction in correlation lengths shown 
by SPECC1L-kd U2OS cells and SPECC1LRRH/300 MEPMs support a role for SPECC1L in 
collective cell migration, as stream formation is a fundamental event in CNCC migration (Tang et 
al., 2007). Protein interactions with SPECC1L support this role as well, as an siRNA mass 





correlated with three major signaling hubs, actin, integrin β1 and β-catenin (Simpson et al., 2008). 
These findings support a novel role for SPECC1L in collective migration, given its regulation of 
AJs, highlighting the importance of cell-cell interactions in CNCC collective migration (Rørth, 
2009). 
 The responsiveness of our U2OS model to PI3K-AKT modulation compliments our 
previous reports highlighting its role in rescuing SPECC1L-kd morphological and AJ phenotypes 
(Chapter Three). A tempting speculation involves the reported role of PI3K-AKT signaling in 
collective migration, where others have shown that PI3K inhibition leads to a reduction in AKT 
regulation of Paxillin α (Paxa), resulting in impaired cytoskeletal reorganization and subsequent 
migration defects (Chung et al., 2001). 
Impaired cytoskeletal reorganization has already been implicated in impaired collective 
migration (Tobin et al., 2008). Interestingly, others have recently reported that in MDCK epithelial 
cells, migrating streams can be understood as a ‘leader’ cell at the forefront of migration being 
followed by numerous ‘follower’ cells. In accord with the aforementioned screen for genes 
responsible for collective migration, PI3K and Integrin β1, are upregulated in leader but not 
follower cells, as well as their specific localization to the leading-edge guiding stream migration, 
which is not observed in follower cells (Yamaguchi et al., 2014). Thus, we propose a novel role 
for SPECC1L in the process of collective migration of CNCCs, through its regulation of AJs and 
























Chapter Five: Discussion 
5.1 Discovery of SPECC1L disruption in atypical facial clefting 
Prior to my studies, the gene encoding the cytoskeletal protein Sperm antigen with calponin 
homology and coiled-coil domains 1-like (SPECC1L) was the first gene implicated in severe 
atypical facial clefting (Saadi et al., 2011). SPECC1L was identified in this study, from a balanced 
chromosomal translocation between chromosomes 1 and 22, harbored by a neonate with atypical 
facial clefting (Dasouki et al., 1988). Mouse in situ hybridization shows prominent expression of 
Specc1l in the maxillary prominence and lateral nasal processes which fail to fuse in ObFC, as 
well as the eyes and limbs, at embryonic day E9.5-E10.5 (Saadi et al., 2011). Further support for 
SPECC1L involvement in atypical facial clefts came with the identification of a de novo 
heterozygous missense mutation in SPECC1L, p.Gln415Pro (Q415P), in a neonate also born with 
severe facial clefts, setting the stage for discovery of multiple SPECC1L mutations in less severe 
forms of clefting (Saadi et al., 2011). 
 
5.2 SPECC1L mutations identified in syndromic clefting 
5.2.1 Role of SPECC1L in the pathogenesis of non-X linked Opitz G/BBB syndrome 
Recently we collaborated with a research group at the Children’s Hospital of Philadelphia, 
on a whole exome sequencing analysis project (Chapter Two). Opitz G/BBB syndrome is a 
developmental disorder primarily characterized by defects in midline development, including cleft 
lip and palate, hypospadias, laryngeal cleft and cardiac defects. This syndrome is known to have 
two inheritance patterns, either X-linked or autosomal dominant. The causative gene inducing the 
X-linked form of Opitz has been identified as Mid1 encoding a microtubule-associated protein 
with E3 ubiquitin ligase activity. Previously, the gene responsible for the autosomal dominant form 
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of Opitz was only known to reside within a 32 cM sequence of chromosome 22q11.2. Results from 
two families with three generations of reported Opitz-like features also negative for MID1 
disruption revealed two separate heterozygous mutations within the coding region of SPECC1L. 
The proband of Family A was identified through multiple defects, including congenital 
hypertelorism and cleft lip and palate. Sequencing analysis revealed that the proband harbored a 
heterozygous missense mutation in SPECC1L, c.1189A>C (T397P), in the second coiled coil 
domain whose disruption was previously shown to cause severe atypical facial clefting (Saadi et 
al., 2011). 
Adding to this relationship was the discovery of an additional heterozygous missense 
mutation in SPECC1L, c.3247G>A (G1083S), in the Calponin homology domain (CHD) 
previously shown to abolish microtubule binding in vitro, when removed via mutagenesis (Saadi 
et al., 2011). This mutation in the proband of Family B was a female identifiable by defects 
including cleft lip and palate, as well as hypertelorism. 
These findings were further validated using mutagenesis and transfection of GFP-tagged 
mouse Specc1l constructs for the canonical allele, the mutations identified above, T397P and 
G1083S, as well as the Q415P mutation previously identified in the second coiled coil domain. 
This mutation was found in a neonate with severe atypical facial clefting (Saadi et al., 2011). 
Protein localization analyses suggest that the second coiled coil domain and the CHD are involved 
in microtubule interactions. Lastly, Specc1l lacking the carboxyl terminal Calponin homology 
domain (Specc1l ΔCHD) was included as a reference to a complete lack of microtubule association 
(Saadi et al., 2011). 
Ectopic wild type specc1l-GFP associates with a lattice of perinuclear microtubules 
stabilized through the acetylation of α-tubulin. Figure 2.3 shows the results of this and patient 
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mutation Specc1l-GFP transfection. All patient mutations, T397P, G1083S and Q415P show a 
punctate expression indicating failed microtubule stabilization, when compared with wildtype 
SPECC1L-GFP. 
MID1 and SPECC1L are microtubule-associated proteins. Complimenting this similarity 
are reports showing that MID1 associated patient mutations also show defective microtubule 
stabilization, in similar assays, suggesting a specific role for microtubule regulation in midline 
development which either MID1 or SPECC1L disruption can impair, resulting in Opitz G/BBB 
syndrome. 
 
5.2.2 Role of SPECC1L in Teebi hypertelorism syndrome 
Additional findings have shown a specific role for this protein in the subtler aspects of 
midfacial development which are less severe than orofacial clefting. Teebi hypertelorism 
syndrome is an autosomal dominant disorder first described by Dr. Ahmad Teebi (Teebi et al.,  
1987). It includes a range of phenotypes include hypertelorism, prominent forehead, long palpebral 
fissures, heavy and broad eyebrows, widow's peak, broad and depressed nasal bridge, short nose, 
mild interdigital webbing, and shawl scrotum. Developmental delays have also been observed, but 
not in all cases. 
Through whole exome sequencing of 19 families with syndromic craniofacial phenotypes, 
two families previously diagnosed with Teebi hypertelorism syndrome were found to harbor 
deleterious mutations in SPECC1L. The first patient, a 15 year old male, harbored an E420D 
variant obtained through maternal inheritance. The mother of patient one also showed 
hypertelorism and unilateral ptosis, as well as preauricular pits.  Patient one was born with the 
following craniofacial abnormalities – hypertelorism, a larger than average distance between the 
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ocular orbits, natal teeth, a premature emergence of neonatal teeth which typically emerge after 
birth, micrognathia, as well as preauricular pits. The patient also had bilateral ptosis and 
craniosynostosis which were surgically addressed previously.  
Non-craniofacial findings included two-vessel cord, a deformation of the umbilical cord 
causing it to lack one of the two arteries typical of the three-vessel structure observed in normal 
development, as well as protruding umbilicus and shawl scrotum, small hands, hypersegmented 
vertebrae and cardiac defects, surgically addressed previously.  
The second patient harbors a de novo SPECC1L mutation which deletes Isoleucine 400 in 
the I400 and Histidine 401 (I400_H401del) in the second coiled coil domain. The second patient 
shared many of the same features seen in the first, including hypertelorism, natal teeth and 
upslanted palpebral fissures and cardiac deformities. Findings unique to Patient one included 
omphalocele, the need for tracheostomy and assisted ventilation in the first six months of life, as 
well a later diagnosis of autism and behavioral issues. 
SPECC1L mutations observed in these Teebi syndrome patients are of further interest 
because they are within the second coiled coil domain disrupted by SPECC1L mutations observed 
in more severe Opitz G/BBB syndrome at T397P (Kruszka et al., 2015), as well as the most severe 
atypical facial clefting mutation Q415P (Saadi et al., 2011), both of which involve orofacial 
clefting. Interestingly, no molecular pathogenetic mechanism has been proposed to describe Teebi 
hypertelorism prior to this study, which caused the authors to suggest that this syndrome may be 
in fact a milder phenotype in a range of SPECC1L phenotypic severity where severe atypical 
clefting is the most deleterious manifestation. These results support including SPECC1L mutation 
screening in future genetic workups of Teebi hypertelorism patients. Placing Teebi hypertelorism 
into a range of phenotypic severity associated with SPECC1L disruption is supported by the 
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description of a family with Teebi hypertelorism where all six affecteds showed a high arched 
palate, with one affected showing cleft lip and palate (Morris et al., 1987). 
 
5.3 SPECC1L patient mutations may disrupt a conserved coiled coil domain 
5.3.1 Conserved domains within SPECC1L harbor human mutations 
One explanation for the impact of the described human mutations involves the two highly 
conserved regions within SPECC1L which harbor them. Although no known orthologs of Specc1l 
more ancient than the CG13366 gene found in Drosophila melanogaster (Saadi et al., 2011) have 
been described, the sequences of the second coiled-coil domain and calponin-homology domain 
(CHD) containing human patient mutations share high homology across the animal kingdom. 
Chordate and insect species along with a platyhelminth and an echinoderm all express 
proteins which contain conserved domain architectures similar to SPECC1L, including a 
conserved coiled coil domain and a singular carboxyl-terminal CHD. The orientation of these 
domains offers a point of initial interest, as CHDs are frequently amino-terminal and often found 
in repetition, with singular carboxyl-terminal compositions less frequent (Korenbaum & Rivero, 
2002). Analysis of proteins with putative Specc1l homology show that the insect species 
Anopheles gambiae (gi 158290650 ref XP), Drosophila melanogaster (gi 24638896 ref NP5), 
Tribolium  castaneum (gi 91085061 ref XP 9) and Apis mellifera (gi 110766125 ref XP) share 
higher homology to each other than to the echinoderm Strongylocentrotus purpuratus (gi 
115627978 XP), the platyhelminth Schistosoma mansoni (gi 256073851ref XP) or Homo sapiens 
(gi 300669640 sp Q69Y), as would be expected from their respective phyla (Fig. 5.1A). 
The previously reported coiled coil mutations T397P (Kruszka et al., 2015), Q415P (Saadi 







acid sequence of conserved peptides ostensibly shared with the last common ancestor of 
Strongylocentrotus purpuratus (gi 115627978 XP) and Homo sapiens (gi 300669640 sp Q69Y), 
circa 500 million years ago, suggesting that the conservation of this region may reflect a critical 
function (Fig. 5.1B). Similarly, the G1083S mutation (Kruszka et al., 2015) impacts the amino-
terminal portion of the CHD in the same proteins, whose conservation is nearly complete at this 
locus, excepting the most removed species, Strongylocentrotus purpuratus (gi 115627978 XP) 
(Fig. 5.1B). 
 
5.3.2 SPECC1L mutation may disrupt conserved regions which likely bind microtubules 
Use of the MAPanalyzer algorithm (Zhou et al., 2015) reveals that the conserved region of 
the second coiled-coil domain affected by human mutations is a predicted high-probability 
microtubule-binding region (Fig. 5.1C, CCD). The amino-terminal region of the CHD affected by 
patient mutation G1083S is also a high-probability microtubule binding region (Fig. 5.1C, CCD) 
(Lupas et al., 1991).  This offers a mechanism by which mutations in these domains disrupts 
SPECC1L colocalization with microtubules, as seen upon expression of these mutant variants 
(Kruszka et al., 2015). 
Human mutations observed throughout the range of clefting severity are likely to impact 
protein function in two principal ways. Coiled coil domain structure emerges from a heptad repeat 
of amino acid chemistries, H-(hydrophobic)-C/P (charged/polar)-C/P-Leu-C-C/P-C (Lupas et al., 
1991). Both Q415P (Saadi et al., 2011) and T397P (Kruszka et al., 2015) substitute large polar 
side chain-bearing residues Glutamine or Threonine with the compact residue Proline. These 
substitutions are likely to disrupt coiled coil dimerization, as shown in solved structures where 
Proline mutations introduce a peptide kink disrupting the conformation of the entire coiled coil 
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(Woolfson & Williams, 1990). Y2H protein interaction screens have provided multiple interactors 
with proteins containing coiled-coil domains (unpublished), suggesting that patient mutations may 
disrupt these interactions, which should be studied in the future. 
Similarly, the I400_H401 deletion (Bhoj et al., 2015), like any deletion, will disrupt the 
coiled coil heptad repeat, with unpredictable consequences for structure and subsequent function. 
Interestingly, the other mutation associated with the milder phenotype of Teebi hypertelorism 
syndrome, E420D (Bhoj et al., 2015) substitutes Glutamic acid with Aspartic acid, both similar 
and negatively charged residues which may disrupt coiled coil structure and function less severely, 
as it does not disrupt the basic chemistry of the heptad repeat. 
Lastly, the G1083S mutation substituting Glycine with Serine in the highly-conserved 
region of the CHD also has a plausible disruptive effect, as missense mutations in the CHD have 
been shown to alter its structure and function, with such mutations suspected in Duchenne 
muscular dystrophy (Norwood et al., 2000). Additionally, G1083S potentially introduces a 
phosphorylation site which could also disrupt CHD function. Phosphorylation of similar proteins, 
such as serine 175 of chick Calponin, are reported to change its conformation (Pin et al., 2000). 
Also, the already described phosphorylation of Serine 1081 in SPECC1L shows that its CHD is 
interacting with an undescribed protein kinase (Hornbeck et al., 2011). 
As mentioned previously, mutations in this coiled coil can introduce a kink in the domain, 
which could interfere with protein-protein interactions. A recent yeast two-hybrid screen for 
SPECC1L protein interactors yielded 6 protein interactors of direct relevance to microtubule 
binding, AKT signaling and AJ regulation. Microtubule motor proteins Kinesin 4A (KIF4A) and 
Kinesin 5C (KIF5C), as well as the microtubule severing protein Spastin (SPAST) interact with 
SPECC1L, offering a possible mechanism for defective microtubule organization seen in patient 
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mutations (Kruszka et al., 2015). Protein inhibitor of activated STAT 1 (PIAS1) facilitates the 
stabilizing sumoylation of AKT, discussed below, while Protein inhibitor of activated STAT 2 
PIAS2 stabilizes the interactions between Ubiquitin conjugating enzyme E2 I (UBE2I), another 
SPECC1L interactor, with its substrates (Hillgarth et al., 2004). This suggests a role for SPECC1L 
in the regulation of protein stability and degradation relevant to the phenotypes seen upon its 
deficiency. Most important to the regulation of AJ stability, interactor SMARCA4 has been shown 
to be a corepressor of ZEB1, which leads to the dissolution of AJs, seen in vitro, as well as the 
defective EMT shown by the neural crest of Specc1l-genetrapped mutant embryos.  
Collectively, all patient mutations examined in this study have plausible consequences 
upon the structure and function of SPECC1L, with severe disruptions correlating with severe 
clefting (Saadi et al., 2011) and functionally milder mutations unlikely to disrupt the heptad repeat 
perhaps equating to the less severe disruption seen in Opitz G/BBB and Teebi hypertelorism 
syndromes (Kruszka et al., 2015, Bhoj et al., 2015). This suggests that the coiled coil interactors 
of SPECC1L may separate the severe and mild developmental phenotypes observed and should be 
considered in future studies. 
 
5.4 SPECC1L is a novel regulator of AKT signaling 
5.4.1 SPECC1L deficiency results in a reduction in pan-AKT protein levels 
Previously, we reported that the severe gene trap Specc1l mouse mutant is embryonic lethal 
at E9.5, showing reduced size compared with WT stage matched littermates, as well as unfused 
neural folds, with a Wnt1-GFP expressing population of cells containing the CNCCs still 
incorporated into the neural folds (Chapter Three). Protein lysates from these severe Specc1l 
mutants shows reduced pan-AKT levels, compatible with reduced embryonic size. Subsequent 
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analysis did not reveal a significant difference in AKT transcription, leaving the possibility that 
SPECC1L deficiency disrupts a fundamental process stabilizing AKT protein or preventing its 
degradation. Further studies indicated that the SPECC1L-kd alteration of cell shape and AJ 
patterning seen in an in vitro model using U2OS cells were prevented by small molecule AKT 
activation by SC79. WT cells can also show SPECC1L-kd phenotypes by inhibition of upstream 
PI3K, using Wortmannin. Interestingly, SPECC1L-kd cells show a stark vulnerability to 
Wortmannin induced apoptosis, when compared with WT U2OS cells which showed no cell death 
upon the same exposure conditions, indicating that SPECC1L-kd cells already have reduced AKT 
and downstream resistance to apoptosis. 
 
5.4.2 Possible mechanisms by which SPECC1L reduces pan-AKT protein levels 
One of the most intriguing findings of these studies was the discovery that reduction in 
SPECC1L yields a dramatic reduction in pan-AKT protein level, with subsequent chemical 
activation of remaining AKT rescuing morphological and cytoskeletal defects in SPECC1L-kd 
U2OS cells. There are several possible mechanisms by which SPECC1L could facilitate AKT 
protein stability. 
 
5.4.2.1 AKT stabilization through mTOR signaling 
Nascent AKT protein is unstable, and its ubiquitination leads to protein degradation by the 
ubiquitin proteasome system (Facchinetti et al., 2008). Nascent AKT can be stabilized upon 
association with heat shock protein 90 (HSP90). However, when HSP90 activity is blocked, a 
subsequent rescue pathway can also stabilize nascent AKT, through the master target of 
Rapamycin complex 2 (mTORC2) proteins, which phosphorylate AKT at Threonine 450. I 
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hypothesize that SPECC1L may facilitate one of these rescue pathways. SPECC1L may shield 
nascent AKT from ubiquitination or encourage the assembly of proteins involved in stabilizing it. 
However, a search of the literature and Y2H protein interactors with SPECC1L show no interaction 
among mTOR proteins of either complex 1 or 2, HSP90 or even AKT itself. However, SPECC1L 
does interact with two ubiquitin-specific peptidases which deubiquitinate proteins (USP10, 
USP15). Thus, we cannot yet discount the possibility that SPECC1L facilitates the de-
ubiquitination of nascent and unstable AKT protein (Fig 5.2, A). 
 
5.4.2.2 AKT stabilization through PIAS1 mediated SUMOylation 
Another possible mechanism involves the stabilizing effects of small ubiquitin-related 
modifier (SUMO) proteins (Li et al., 2013). Recent work has highlighted the importance played 
by SUMO-induced protein stabilization, including stabilization of AKT itself (Li et al., 2013). Li 
and colleagues found that AKT lysine 276 is sumoylated by SUMO1, via the Sumo E3 ligase 
Protein inhibitor of activated STAT1 (PIAS1). Interestingly, mutagenesis of this residue results in 
dramatic loss of AKT kinase function, yielding reduced proliferation and migration delay in wound 
assays using H1299 cells derived from non-small cell lung carcinoma (Li et al., 2013). Supporting 
these findings, increased PIAS1 increases AKT kinase activity, while increased sumo-specific 
protease (SENP1) decreases AKT kinase activity (Li et al., 2013). Supporting a role for SPECC1L 
in this interaction, our Y2H screens for SPECC1L protein interactors revealed binding with both 
PIAS1 and SUMO1, while not associating with its counterpart, SENP1. Perhaps a more robust 
hypothesis regarding SPECC1L stabilization of AKT involves sumoylation at K276 via 
conjugation of SUMO1 by PIAS1 (Figure 5.2B, C). SPECC1L interacts with numerous proteins 





ligase HERC2 (Wu et al., 2010) as well as ubiquitin specific peptidases 10 (USP10) and 15 
(USP15) (Nijman et al., 2005), suggesting a generalized role for SPECC1L in facilitating the post-
translational modification and subsequent regulation of multiple substrates. 
 
5.5 SPECC1L role in CNCC delamination 
5.5.1 SPECC1L deficiency alters AJ patterning in vitro and in vivo 
Chapter Three detailed how SPECC1L-kd U2OS cells, staining of canonical adherens 
junction (AJ) components, β-Catenin and E-Cadherin, was increased, and electron micrographs 
revealed an apico-basal diffusion of AJs. To understand the role of SPECC1L in craniofacial 
morphogenesis, we generated a mouse model of Specc1l deficiency. Homozygous mutants were 
embryonic lethal and showed impaired neural tube closure and CNCC delamination. Staining of 
AJ proteins was increased in the mutant neural folds. This AJ defect is consistent with impaired 
CNCC delamination, which requires AJ dissolution. Importantly, AJ changes induced by 
SPECC1L-knockdown were rescued by activating the PI3K-AKT pathway in vitro. Together, 
these data indicate SPECC1L as a novel modulator of PI3K-AKT signaling and AJ stability, 
required for neural tube closure and CNCC delamination. 
 
5.5.2 Possible mechanisms through which SPECC1L modulates AJs. 
5.5.2.1 SPECC1L interactor SMARCA4 corepresses ZEB1 transcription, potentially 
impacting AJ patterning 
There are multiple, plausible mechanisms which can explain how SPECC1L deficiency 
disrupts AJ patterning. The first involves the role played by SPECC1L interactor SMARCA4 as a 
corepressor of E-Cadherin transcription (Sanchez-Tillo et al., 2010). This mechanism would 
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require SPECC1L facilitation of SMARCA4 binding to a regulatory element of this gene, whose 
repression is an important element of EMT (Duband et al., 2015). Immunostaining using an 
antibody detecting SPECC1L shows it within the nucleus. Also, some of its interactors are 
involved in chromatin regulation, so a role for it in the nucleus, in transcriptional regulation cannot 
be ruled out. Exploration of this potential mechanism could be accomplished by introducing 
exogenous SPECC1L mutagenized to remove any nuclear localization signal and a subsequent 
analysis of Zeb1 expression. 
 
5.5.2.2 Reduced AKT levels upon SPECC1L deficiency lead to increased β-Catenin 
association with AJs 
A mechanism more supported by the findings of this study involves AKT signaling itself, 
in the altered AJ patterning resulting from SPECC1L deficiency. Previously, deficiency of a 
catalytic subunit of PI3K, upstream of AKT, was shown to induce a similar disruption of AJ 
patterning (Cain et al., 2010). AKT has been shown to phosphorylate β-Catenin at serine 552, 
which promotes its dissociation from AJs, promoting its nuclear localization and subsequent 
transcription of Wnt target genes (Nelson 2004). If, upon SPECC1L-kd, reduced AKT signaling 
leads to reduced dissociating phosphorylation, this very direct mechanism could be explored with 
Western blotting of WT and SPECC1L-kd cell lysates for phospho-552 β-Catenin and a 
comprehensive comparison of nuclear versus membrane associated β-Catenin. 
 
5.5.2.3 SPECC1L may facilitate AJ recycling through Clathrin-mediated endocytosis 
We reported that SPECC1L interacts with both E-Cadherin and β-Catenin, two canonical 
AJ components. It has been reported that endocytosis of entire AJs is also a mechanism in 
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controlling intracellular adhesions, allowing the possibility that this binding may affect junction 
recycling (Harris & Tepass, 2010). 
Clathrin-mediated endocytosis (CME) begins with membrane nucleation around a target 
cargo destined for internalization through preceding modifications of that target. SPECC1L protein 
interactors AMOTL2 (Li et al., 2012) and HIPK2 (Kim et al., 2010) are negative regulators of AJ 
stability, (Fig 5.3A). This targeting process also requires cargo-specific adapter proteins (Sorkin 
2004). As SPECC1L interacts with both AJ components and negative regulators of AJ stability, 
presumably at the plasma membrane, it is possible that SPECC1L is an adapter protein facilitating 
AJ recycling. 
The endocytic organizer Adaptor Protein 2 (AP2) binding is required for clathrin coat 
assembly to proceed (Henne et al., 2010). SPECC1L interacts with Arrestin β2 (ARRB2), which 
is involved in internalization of ligand-bound receptors in this process (Chen et al., 2004). 
Interestingly, disruption of AP2 subunit β1 has been shown to result in cleft palate in mice, 
suggesting a role for CME in palatogenesis (Li et al., 2012). Indeed, a study of Drosophila 
embryogenesis has shown that E-Cadherin endocytosis is coordinated in an AP2-dependent 
mechanism which, when defective, causes cell-cell intercalation defects (Levayer et al., 2011). 
  Additional SPECC1L interactors critical to CME include vesicle scission protein Cortactin 
(Fig 5.3C) (Cao et al., 2003) and a lipid phosphatase, Synaptojanin, which liberates clathrin from 
the vesicle coat, enabling the uncoating process (Fig 5.3D) (Verstreken et al., 2003). Finally, 
SPECC1L interacts with actin-based motor proteins involved in CME, such as Myosin IIIA 
(MYO3A) and Myosin VC (MYO5C) (Kaksonen et al., 2006). As our protein interactor screen 
yielded approximately 80 proteins, it seems unlikely that its association with ten proteins involved 







Previous work has shown that a reduction of the clathrin adapter protein Disabled homolog 2 
(DAB2) results in a loss of apical polarization of E-Cadherin (Yang et al., 2007) (Fig 5.3A). This 
mechanism could be tested by co-immunostaining of AJ and CME proteins, to investigate 
whether a SPECC1L-kd cell line shows a reduction in internalized AJs. Thus, an investigation of 
any role played by SPECC1L in the CME of AJs should also be included in future efforts. 
Interestingly, AKT and GSK3 regulate CME through the regulation of Dynamin, indicating 
that these two models may be synergistic, rather than mutually exclusive. A synergism between 
these two models, AKT regulation of AJs directly or through CME, would also explain the partial 
rescue of the SPECC1L-kd AJ and morphology change seen upon GSK3 inhibition, as compared 
with the far more robust rescue seen with activation of its upstream negative regulator AKT, in 
SPECC1L-kd U2OS cells (Chapter Three). 
 
5.6 SPECC1L deficiency affects cell morphology through PI3K-AKT signaling. 
5.6.1 AKT regulates cell shape through Rho GTPase-activating protein RHOGAP22 
A potential mechanism, which could explain both altered cell shape and migration, 
involves reduced activation of RHOGAP22 by AKT, upon SPECC1L deficiency. RHOGAP22 
phosphorylation by AKT facilitates its binding with the scaffold protein 14-3-3, a prominent 
mediator in translating AKT substrate phosphorylation into cellular processes (Rowland et al., 
2011). Upon AKT-induced association with 14-3-3, RHOGAP22 inhibits RAC1 regulated 
lamellipodia formation, a critical factor in cell migration, as surplus lamellipodia signal a transition 
from directional migration to a more amoeboid and less directed motility (Rowland et al., 2011). 
However, of direct relevance to cell shape is the effect Ras-related C3 Botulinum Toxin 
Substrate 1 (RAC1) exercises upon the actin cytoskeleton, encouraging protrusive actin 
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polymerization and subsequent cell elongation, antagonizing Ras Homolog Family Member A 
(RHOA) promotion of contractile actin, as observed during lens pit morphogenesis (Chauhan et 
al., 2011). Indeed, inactivation of RHOGAP22 yields reduced cell circularity in vitro (Rowland 
2011). This mechanism would also explain altered actin architecture upon SPECC1L-kd, given 
RAC1 function is promoting actin protrusion (Chauhan et al., 2011). 
 
5.6.2 FoxO1 and mTOR regulate cell elongation through PI3K-AKT signaling 
An alternative explanation was recently explored. After publication of our report showing 
that PI3K inhibition is sufficient to induce elongation and AKT activation is sufficient to rescue 
elongation upon SPECC1L-kd, Tsuji-Tamura and colleagues showed that inhibition of PI3K, AKT 
or mTORC1 was sufficient to induce elongation in endothelial cells (Tsuji-Tamura & Ogawa, 
2016). This suggests that mTORC1 regulation of the actin cytoskeleton may be involved in 
SPECC1L-kd based elongation, through inhibition of RHOA, which promotes contractile actin, as 
opposed to RAC1, which promotes protrusive actin (Liu et al., 2011). However, as mTORC1 
regulates RHOA and RAC1 regulates mTORC1 (Saci et al., 2011), the two mechanisms proposed 
may well be interdependent. 
 
5.7 SPECC1L deficiency impairs collective cell migration in vitro 
5.7.1 Altered actin arrangement upon SPECC1L-kd may affect migration 
In Chapter Three, we reported that upon SPECC1L-kd U2OS cells show altered actin 
architecture, featuring longer actin stress cables associated with Myosin. This most basic feature 
of SPECC1L deficiency, cytoskeletal alteration has likely consequences upon the mechanical 
forces which these cells can exert, given the strong Myosin association with these stress cables. 
Collective cell motions were previously expected to originate with traction forces exerted by so 
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called ‘leader’ cells at, for example, the edge of a wound assay (Trepat et al., 2009). However, 
direct measurement of these traction forces show that the mechanical force required for collective 
cell migration originate in and are mainly generated by cells multiple rows behind the cells of the 
leading edge, showing that force generation is more of an aggregate property of a cell line, rather 
than just a traction force at the leading edge (Trepat et al., 2009). Thus, alteration of actin 
architecture seen upon SPECC1L-kd and the myosin motor forces generated using it are relevant 
variables in collective cell migration. Indeed, this altered actin architecture can be explained by 
AKT signaling deficiency, as RAC1 is inactivated by it (Kwon et al., 2000), with more activated 
RAC1 encourage actin protrusions (Chauhan et al., 2011) and ostensibly subsequent elongation. 
Also, activation of depolymerization factor Cofilin 1 (CFL1) promotes the disassembly of 
actin fibers. Akt activates (SSH1L), which activates Cofilin 1 through removal of an inhibitory 
phosphorylation (Oh et al., 2007). Thus, it is plausible that reduced Akt upon SPECC1L deficiency 
reduces the level of active Cofilin 1 available to depolymerize actin filaments, offering a 
mechanism for altered actin architecture (Nishita et al., 2004).  
 
5.7.2 SPECC1L-kd may impact collective migration through reduced AKT regulation of 
MERLIN 
  A frustration to those researching collective cell migration is the relative lack of proteins 
implicated in its accomplishment. However, one exception offers an alternative mechanism 
through which SPECC1L deficiency could impair collective migration, in the junctional protein 
encoded by the Neurofibromatosis type II gene, MERLIN (Das et al., 2015). Acting as a 
mechanochemical transducer, MERLIN spatially organizes collective migration by the dynamic 
localization of RAC1, with respect to the direction of migration (Das et al., 2015). Thus, MERLIN 
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is one of the only proteins whose disruption reduces the correlation lengths of migrating streams. 
While some models place RAC1 upstream of MERLIN, others report the opposite relationship, 
with the authors concluding the relationship is spatiotemporally dependent (Das et al., 2015). AKT 
engages in regulatory phosphorylation of both proteins (Kwon et al., 2000, Tang et al., 2007), 
establishing a plausible model for how SPECC1L disruption or deficiency would cause a reduction 
in the correlation lengths of migratory streams. While reduced AKT signaling would derepress 
MERLIN (Tang et al., 2007), its spatiotemporal dynamic with RAC1 strongly suggests that surplus 
MERLIN could also negatively affect the arrangement of collective migration. The mechanism 
proposed here would also explain the results of our ongoing work, in which chemical activation 
of remaining AKT by SC79 rescues closure time in SPECC1L-kd U2OS wound cultures, 
independently of changes in velocity. 
 
5.8 Conclusion: Severity of SPECC1L mutations affects the extent of disruption 
5.8.1 Importance of considering the dose dependent effects of SPECC1L disruption 
The role of SPECC1L in mitosis only requires one functional allele, as a deficiency greater 
than 50 percent reduction was required to produce the defective spindle rocking phenotype 
(Mattison et al., 2011). Also, in vivo disruption of SPECC1L as severe as our gene-trap Specc1l 
mutants will not yield viable organisms for investigation. Effectively, severe SPECC1L deficiency 
prohibits investigation of craniofacial dysmorphology. 
As various embryonic cell lineages have variable needs in terms of their respective rates of 
proliferation, speed of migration and resistance to apoptosis, it seems reasonable to hypothesize 
that different lineages either express lineage-specific AKT stabilizing proteins, or show variability 
in their transcription rates of them, with respect to lineage. It is possible that SPECC1L is the AKT 
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stabilizing protein of CNCCs, and milder disruptions of SPECC1L function yield defects specific 
to craniofacial morphogenesis. 
 
5.8.2 A mechanism by which SPECC1L stabilizes AKT at the membrane 
I have synthesized the following model based on my work and published findings. As the 
listing of assumptions is a necessary component in the evaluation of any kind of model, they are 
below noted by a preceding “*”. 
*Upon its translation, SPECC1L travels from the Golgi to the plasma membrane along the 
microtubule cytoskeleton by way of its interactions with microtubule motor proteins KIF4 and 
KIF5c. It has been shown that AKT is activated at the membrane and deactivated in the cytoplasm. 
*Therefore, it seems logical to consider that AKT stabilization also occurs at the membrane, as 
described (Li et al., 2013). Microtubule dynamics regulate this process, suggesting a critical role 
for microtubule cargos in conveyance of AKT signaling (Jo et al., 2014).  
This aspect of SPECC1L transport seems realistic, as SPECC1L has been shown to 
associate with plus end microtubule regulators such as the interaction between SPECC1L ortholog 
CG13366 with Clasp, in Drosophila (Lowery et al., 2010). More recently, plus end microtubules 
were shown to be required for gap junction component delivery to the membrane in a mechanism 
involving β-Catenin and N-Cadherin and the plus end tracking protein Microtubule Associated 
Protein RP/EB Family Member 1 (MAPRE1), showing a role for plus end microtubule cargo 
transport in the maintenance and regulation of membrane complexes (Shaw et al., 2006). *Thus, 
the possibility exists that SPECC1L is such a plus-end microtubule cargo. 
SPECC1L localizes to areas of cell-cell contact, physically interacting with β-Catenin and 
E-Cadherin (Chapter Three), as well as possibly stabilizing AKT so that it can negatively regulate 
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AJs, through a proposed mechanism involving stabilizing sumoylation of nascent, unstable AKT 
via the interaction between SPECC1L and PIAS1, which was shown to facilitate this modification 
(Li et al., 2013)*. 
*Upon anchoring the AJ and enabling the stabilization of AKT, SPECC1L then facilitates 
microtubule severing by its interaction with SPAST (unpublished). Upon stabilization, 
subsequently activated AKT at the membrane negatively regulates AJs through phosphorylation 
of β-Catenin at Ser552, inducing its dissociation from AJs (Fang et al., 2007). It has been shown 
that SPECC1L is an AKT phospho-substrate (Lee et al., 2014, Fantauzzo & Soriano, 2014), but 
its function has not been explored. *Thus, it is possible that AKT phosphorylation of SPECC1L 
releases it from AJ components, forming a feedback loop. 
*It seems logical that such a feedback loop would exist to tether the processes of AKT 
stabilization and the negative regulation of AJ stability, as AJs must be recycled to facilitate AKT 
promoted processes such as migration. Supporting this model, it has been shown that disruption 
of the microtubule cytoskeleton inhibits AKT signaling and stabilization of microtubules sustains 
it (Jo et al., 2014).  
It has also been shown that SPECC1L interactions with the actin cytoskeleton are best 
visualized upon treatment with Nocodazole, disrupting its interaction with the MT cytoskeleton 
and that SPECC1L colocalizes with F-actin throughout the cytoplasm, not just cortical actin (Saadi 
et al., 2011). *Thus, upon AJ release, SPECC1L leaves the membrane via Myosin interactions 
with the actin cytoskeleton. This explains its colocalization with both cytoskeletons (Saadi et al., 
2011). *As it serves an unknown nuclear role in addition to those described, its trafficking between 
the two is logical. Protein complexes linking actin filaments with nuclear pore complexes have 




5.8.3 Hypothesis: SPECC1L mutations cause a continuous range of AKT stability 
*The ΔCHD deletion is incapable of interacting with either the actin or microtubule 
cytoskeletons, causing its uniform cytoplasmic pattern, suggesting that actin binding is primary to 
a secondary yet also functionally important association with the microtubule cytoskeleton, 
dependent upon it. As such, the Q415P mutant SPECC1L found in severe ObFC, which contains 
an unaffected CHD, still defectively associates with the MT cytoskeleton. 
*The Q415P mutation is more deleterious than the T397P mutation, despite their similar 
Proline substitution outcomes. *This can be explained as a differential effect shown by Proline 
mutations in coiled coils, as they are more deleterious when occurring near the center of the coil, 
introducing a kink, as opposed to its amino or carboxyl ends. 
*The Q415P mutation induces a kink in the second coiled coil which disrupts a category 
of protein-protein interactions with the second coiled coil, perhaps microtubule motor proteins 
KIF4 or KIF5c. *The T397P mutation does not induce a kink in the second coil domain, or its 
influence is muted because of its closer proximity to the edge. 
*Thus, if a Q415P kink induced in the second coil is sufficiently disruptive, it could prevent 
SPECC1L transport to the membrane along the microtubule cytoskeleton, assuming that kinesin 
binding to SPECC1L is severely reduced by that kink. This may explain why the ΔCHD deletion 
and Q415P were both isolated from severe clefting patients. Severe lack of AKT stabilization 
specific to CNCCs may be impairing the proliferation and migration of the early facial 
prominences enough to prevent their having sufficient tissue to ultimately juxtapose. Indeed, 
reduced neural crest proliferation has been noted in another craniofacial dysmorphology, Treacher 
Collins syndrome (Trainor, 2010). 
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  *It seems reasonable to propose that mutations in coiled coil domains would generate a 
range of reduction in loading SPECC1L-bound kinesins with microtubules and a subsequent range 
of reduced AKT stabilization. Thus, the level of disruption each mutation causes to this domain 
may directly translate into an equivalent reduction in AKT stabilization, yielding a range of 
outcome severities. AKT stabilization via SPECC1L-PIAS1-SUMO1, or an unknown equivalent 
mechanism, is thus a continuous, rather than a discrete range, where, for example, a given mutation 
might cause a 20% reduction in the rate of the reaction, leading to a 10% reduction is stabilized 
AKT, after considering zygosity. This would then yield a milder phenotype than a mutation that 
reduced that reaction rate by 30%. 
Intermediate severity syndromic clefting seen upon SPECC1L disruption may be caused 
by an intermediate level of reduced AKT levels, resulting in impaired cross-talk with other 
pathways involved in facial development. Growth factor signaling upstream of PI3K-AKT 
signaling, such as EGFRs engage in cross talk with SHH pathway, via Gli1 (Gotschel et al., 2013), 
where SHH signaling informs midline spatial organization, as seen in its role in the pathogenesis 
of hypertelorism (Brugmann et al., 2010), which is also a defining symptom of Opitz G/BBB 
syndromes associated with SPECC1L mutations (Kruszka et al., 2015). 
The findings of these studies and proposed models of pathogenesis of SPECC1L deficiency 
in orofacial clefting will serve to enhance our knowledge of the role of this protein in cranial facial 
morphogenesis. 
 
5.9 Clinical significance 
Orofacial clefts including cleft lip and palate are frequent congenital malformations. The 
CDC estimates that approximately 7,000 U.S. children are born with cleft lip and or palate 
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annually, making it one of the most frequent malformations. The average cost of cleft lip and palate 
repair surgery is over 20,000 dollars and frequently exceeds this when multiple surgeries or other 
treatments are required. While over 400 genes have been linked to rarer syndromic facial clefting 
disorders, much less is known regarding the underlying pathogenesis of more frequent and 
typically idiopathic non-syndromic facial clefts and the environmental risk factors which increase 
occurrence. 
One aspect of the clinical significance of this study is its demonstration of the role of PI3K-
AKT signaling in facial morphogenesis generally and specifically, the novel role played by 
SPECC1L in AJ regulation throughout that process. Expanding our knowledge of cell junction 
biology is clinically important, as recent research findings illustrate human mutations affecting 
cell junctions are associated with defects in limb formation, epidermal maintenance and other 
extracutaneous pathologies (Lai-Cheong et al., 2007). 
Further, this study demonstrates a fundamental role for SPECC1L-mediated PI3K-AKT 
signaling in the collective migration of cell populations, during embryonic development. 
Collective cellular movement is fundamental to embryogenesis, with defects impacting not only 
craniofacial formation, but cardiac formation and gut innervation. As neonatal cardiac defects are 
also among the most common and costly malformations (Butler, 2016), furthering our discovery 
and understanding of the factors facilitating collective migration shows neonatal significance. 
Lastly, this study shows the PI3K-AKT signaling pathway as a potential mechanism by 
which prenatal intervention may reduce facial clefting, in at risk pregnancies. Just as Folic acid 
supplementation reduces the occurrence of facial clefting and neural tube defects (Tolarova & 
Harris, 1995), dietary or pharmaceutical treatment modulating downstream effectors of AKT may 
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show a direct clinical application. Conversely, risk of facial clefting may be reduced by prenatal 
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Table A.1. SPECC1L protein interactors from literature search and Yeast-two hybrid screens 
used in Ingenuity pathway analyses and subsequent hierarchical edge bundling 
   
Symbol Protein interactor PMID 
 
ACTB Beta actin 26496610 
AMOTL2 Angiomotin-like protein 2 † 
ANKRD26 Ankyrin repeat domain 26 26496610 
ANLN Anillin 26496610 
AP2M1 Adaptor-related protein complex 2, mu 1 subunit 26186194, † 
APC Adenomatous polyposis coli 20936779 
ARRB2 Beta arrestin-2 † 
ATAD2 ATPase family AAA domain-containing protein 2 † 
ATBF1 Zinc finger homeobox protein 3 † 
ATMIN ATM interactor ‡ 
BEGAIN Brain-enriched guanylate kinase-associated protein † 
C10ORF2 Chromosome 10 open reading frame 2 26496610 
CABIN1 Calcineurin-binding protein cabin-1 † 
CALML3 Calmodulin-like 3 26496610 
CAPZA2 Capping protein muscle Z-line, alpha 2 26496610 
CCDC8 Coiled-coil domain containing 8 24711643 
CCNJ Cyclin J ‡ 
CDK2 Cyclin-dependent kinase 2 26496610 
CFAP97 Cilia and flagella associated protein 97 † 
CHRNA9 Cholinergic receptor, nicotinic, alpha 9 (neuronal) 26186194 
DBN1 Drebrin 1 26496610 
DDX23 Probable ATP-dependent RNA helicase DDX23 † 
DUSP22 Dual specificity phosphatase 22 ‡ 
ECM29 Proteasome-associated protein ECM29 homolog 20682791 
EDC4 Enhancer of mRNA-decapping protein 4 † 
EDRF1 Putative transcription activator BRLF1 homolog † 
EEF2 Elongation factor 2 † 
FBXO25 F-box protein 25 20473970 
FEZ1 Fasciculation and elongation protein zeta 1 (zygin I) ‡ 
FSCN2 Fascin actin-bundling protein 2, retinal ‡ 
FSD1 Fibronectin type III and SPRY domain containing 1 26186194 
G2E3 G2/M-phase specific E3 ubiquitin protein ligase ‡ 
GLIS2 GLIS family zinc finger 2 17289029 
HERC2 HECT and RLD domain containing E3 ub. ligase 2 25476789 
HIPK1 Homeodomain-interacting protein kinase 1 † 
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Symbol Protein interactor PMID 
   
HIPK2 Homeodomain-interacting protein kinase 2 † 
HMMR Hyaluronan mediated motility receptor † 
IGSF9 Protein turtle homolog A † 
IQGAP1 IQ motif containing GTPase activating protein 1 26496610 
ITGA5 Integrin alpha 5 (fibronectin receptor alpha) 26496610 
KCTD17 Potassium channel tetramerization containing 17 26186194 
KIF4 Chromosome-associated kinesin KIF4A † 
KIF5C Kinesin heavy chain isoform 5C † 
LIMA1 LIM domain and actin binding 1 26496610 
LPXN Leupaxin ‡ 
LRFN4 Leucine rich repeat and FN type III domain 4 26186194 
LUZP4 Leucine zipper protein 4 25662211 
MYH10 Myosin, heavy polypeptide 10, non-muscle 26496610 
MYH9 Myosin, heavy chain 9, non-muscle 26496610, † 
MYO18A Myosin 18A 26496610 
MYO19 Myosin 19 26496610 
MYO1C Myosin 1C 26496610 
MYO5C Myosin 5C 26496610 
MYT1 Myelin transcription factor 1 † 
NCOR1 Nuclear receptor corepressor 1 † 
NFKBIA Nuclear factor of kappa light polypeptide enhancer α 26186194 
NOP14 Nucleolar protein 14 † 
OBFC1 Oligonucleotide-binding fold containing 1 26186194 
PAN2 PAN2 poly(A) specific ribonuclease subunit 23398456 
PDLIM7 PDZ and LIM domain 7 (enigma) 26496610 
PIAS1 E3 SUMO-protein ligase PIAS1 † 
PIAS2 E3 SUMO-protein ligase PIAS2 † 
PPP1CB Protein phosphatase 1, catalytic subunit, β isozyme 26496610 
PPP1R12A Protein phosphatase 1 regulatory subunit 12A † 
PPP1R12C Protein phosphatase 1 regulatory subunit 12C † 
PRDM15 PR domain zinc finger protein 15 † 
RBAK RB-associated KRAB zinc finger protein † 
RCN1 Reticulocalbin 1, EF-hand calcium binding domain 26186194 
RPL15 Ribosomal protein L15 ‡ 
SAFB Scaffold attachment factor B1 † 
SAMM50 Sorting and assembly machinery component 50  26496610 
SETX Probable helicase sentaxin † 
SLC25A41 Solute carrier family 25, member 41 26186194 
SLC30A6 Solute carrier family 30 (zinc transporter), member 6 26186194 
SMARCA4 Transcription activator BRG1 † 
SMARCAD1 SWI/SNF-related regulator of chromatin AD1 † 
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Symbol Protein interactor PMID 
   
SMARCC1 SWI/SNF complex subunit SMARCC1 † 
SMARCE1 SWI/SNF-related regulator of chromatin E1 † 
SNW1 SNW domain-containing protein 1 † 
SPAST Spastin † 
SPC25 SPC25, NDC80 kinetochore complex component 26186194 
SPECC1 Sperm antigen with CHD and coiled-coil domains 1 † 
SRGAP3 SLIT-ROBO Rho GTPase-activating protein 3 † 
SYNPO Synaptopodin 26496610 
TDG G/T mismatch-specific thymine DNA glycosylase † 
TNFRSF22 TNF receptor superfamily member 22 † 
TOX3 TOX high mobility group box family member 3 † 
UBC Ubiquitin C 23314748 
UBE2I SUMO-conjugating enzyme UBC9 20936779, † 
USO1 USO1 vesicle docking factor 26496610 
USP15 Ubiquitin carboxyl-terminal hydrolase 15 † 
VAV1 Vav 1 guanine nucleotide exchange factor ‡ 
ZBTB16 Zn finger and BTB domain-containing protein 16 † 
ZBTB41 Zn finger and BTB domain-containing protein 41 † 
ZCCHC7 Zn finger CCHC domain-containing protein 7 † 
ZKSCAN1 Zn finger protein with KRAB and SCAN domains 1 † 
ZSCAN2 Zn finger and SCAN domain-containing protein 2 † 
ZSCAN21 Zn finger and SCAN domain-containing protein 21 † 
 
† Unpublished data from Saadi, I (2016) 
‡ Unpublished data from Huttlin, EL (2014): 
https://thebiogrid.org/166968/publication/the-bioplex-network-of-human-protein-interactions-
additional-unpublished-ap-ms-results.html 
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